data_2a9h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2a9h _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.817 0.341 . . . . 181.62 111.047 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.9 tp -177.23 -44.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 163.38999999999999 110.955 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -55.92 -31.73 63.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 154.91999999999999 110.93 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.405 ' CE3' ' HA ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -76.84 -63.93 1.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 178.34 110.882 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tpp85 -55.43 -51.91 65.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 182.99000000000001 110.9 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.37 -44.21 34.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 172.56 111.109 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.79 -44.34 66.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 108.12 111.12 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.16 -39.13 97.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.691 -0.766 . . . . 114.36 112.528 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.74 -37.59 65.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.822 0.344 . . . . 156.87 111.106 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.86 -39.89 27.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 168.03 111.091 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.75 -35.41 68.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 124.14 110.876 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.24 -46.92 95.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 186.53 111.144 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.17 -59.52 4.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 143.06 110.958 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.72 -38.62 48.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 121.26000000000001 110.979 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.1 t -63.47 -46.72 94.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 91.799999999999997 111.084 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.1 mt -63.96 -62.55 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 116.76000000000001 111.05 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -49.15 -32.35 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 140.44 111.099 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mt -58.9 -64.18 1.03 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 91.799999999999997 110.921 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.17 -54.05 51.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 91.799999999999997 110.937 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.04 -62.79 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 201.16 111.099 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -49.05 -50.84 26.79 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.666 -0.778 . . . . 121.73 112.549 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.0 m -49.14 -56.37 9.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 91.799999999999997 110.956 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -65.11 -35.61 81.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 207.41 110.934 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.61 -46.44 88.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 119.83 110.864 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.28 -43.29 64.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 146.28 111.125 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -48.02 -58.01 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 103.3 111.183 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.17 -31.14 5.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 186.56999999999999 111.002 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.38 -67.9 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 91.799999999999997 111.149 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -48.24 -31.44 5.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 140.74000000000001 110.919 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.66 -46.26 39.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 184.00999999999999 110.925 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.0 49.84 0.82 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.702 -0.761 . . . . 183.50999999999999 112.506 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.9 161.99 27.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 129.59999999999999 111.141 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 87.31 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.752 2.301 . . . . 91.799999999999997 112.314 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -125.12 -172.9 13.56 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.739 -0.743 . . . . 91.799999999999997 112.5 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.96 -70.53 0.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 121.54000000000001 111.088 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -163.89 31.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 91.799999999999997 111.137 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.404 HD21 ' CE3' ' A' ' 68' ' ' TRP . 29.7 mt -92.98 50.88 1.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 91.799999999999997 110.863 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 pt -96.58 -32.21 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 97.340000000000003 111.145 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.09 156.25 24.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 91.799999999999997 110.85 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.446 ' N ' ' CD ' ' A' ' 63' ' ' PRO . 4.9 m-85 -69.78 -47.54 23.86 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 185.28 111.57 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 62' ' ' TYR . 87.6 Cg_exo -46.51 -28.92 6.71 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.102 1.868 . . . . 106.64 112.266 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.41 -45.84 5.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 91.799999999999997 110.887 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.8 -48.91 79.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 93.680000000000007 111.115 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.3 mt -48.4 -42.37 31.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 91.799999999999997 110.876 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -36.75 85.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 92.480000000000004 110.836 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.404 ' CE3' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -66.54 -40.55 89.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 91.799999999999997 110.856 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.9 m -62.63 -42.89 99.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 91.799999999999997 110.868 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.71 -50.71 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 91.799999999999997 111.033 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -63.0 -46.89 85.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 91.799999999999997 110.837 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.1 m -59.25 -32.28 69.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 93.489999999999995 110.853 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.36 -30.51 64.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 91.799999999999997 111.144 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 m -98.17 29.64 3.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 91.799999999999997 111.067 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 50.1 p 47.94 32.59 2.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.347 -0.388 . . . . 91.799999999999997 110.994 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.6 t -90.54 -74.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 146.84999999999999 111.108 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 56.53 69.89 1.14 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.698 -0.763 . . . . 148.34 112.485 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -48.54 -56.84 7.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 91.799999999999997 110.929 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.45 -31.96 2.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.742 -0.742 . . . . 91.799999999999997 112.502 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -50.54 -52.47 38.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.836 0.35 . . . . 91.799999999999997 110.894 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.77 101.45 9.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 91.799999999999997 110.882 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -125.21 150.8 68.2 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 98.819999999999993 110.912 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.415 ' HG2' ' CH2' ' D' ' 67' ' ' TRP . 66.5 Cg_endo -74.51 159.67 42.65 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.648 2.232 . . . . 91.799999999999997 112.341 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.6 t -139.31 -48.28 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 91.799999999999997 111.035 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.3 m -74.41 160.11 31.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 97.150000000000006 110.797 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.48 -58.25 4.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.418 . . . . 182.22999999999999 110.878 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.14 -58.02 8.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 203.72999999999999 110.863 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -50.07 -44.74 42.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.69 -0.767 . . . . 91.799999999999997 112.382 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -69.17 -40.32 78.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 91.799999999999997 110.78 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.29 -40.25 70.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 123.86 110.818 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.7 t -62.16 -42.48 95.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 91.799999999999997 111.081 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.84 -48.69 69.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 91.799999999999997 111.049 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.0 t -66.39 -41.97 89.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.487 . . . . 91.799999999999997 111.099 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 65.8 t -63.34 -42.14 95.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 91.799999999999997 111.089 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.57 -31.37 32.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 91.799999999999997 111.13 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -51.45 64.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 91.799999999999997 110.858 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.87 -38.35 78.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 91.799999999999997 110.976 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.98 -46.36 68.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 91.799999999999997 111.004 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.72 -42.47 99.68 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.742 -0.742 . . . . 91.799999999999997 112.441 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.444 HD13 HG21 ' A' ' 100' ' ' ILE . 25.3 mt -68.62 -43.8 83.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.348 . . . . 93.590000000000003 111.07 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.8 m -56.97 -48.31 78.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 91.799999999999997 110.853 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -63.57 -40.9 98.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 133.81999999999999 110.862 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.62 -36.89 73.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 91.799999999999997 110.865 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.401 ' HA3' ' CE1' ' D' ' 107' ' ' PHE . . . -59.74 -51.15 60.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 93.930000000000007 112.43 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 mp -50.8 -34.38 27.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.341 . . . . 93.930000000000007 110.819 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.1 t -70.4 -42.86 78.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 91.799999999999997 111.014 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -62.38 -40.8 97.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 91.799999999999997 110.782 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -78.8 -34.64 45.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 91.799999999999997 110.991 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.93 -46.32 74.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 91.799999999999997 111.011 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 m -63.89 -34.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 91.799999999999997 111.056 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.61 92.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 102.69 111.054 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -48.34 82.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 140.03 110.854 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -70.3 -31.5 68.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.472 . . . . 183.49000000000001 110.869 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.409 ' CD2' ' HA ' ' B' ' 25' ' ' HIS . 3.8 m-30 -62.34 -31.5 72.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 127.13 110.909 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.1 t -73.79 -30.65 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 156.63 111.177 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -93.1 66.07 1.87 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.713 -0.756 . . . . 125.69 112.54 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.99 37.27 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 119.23999999999999 110.911 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -48.47 -46.13 37.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 217.47999999999999 110.87 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.206 -0.902 . . . . 193.75 110.867 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.785 0.326 . . . . 173.56999999999999 111.057 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 7.0 tp -177.52 -44.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 159.27000000000001 110.873 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . 0.409 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 8.9 p80 -55.96 -31.68 63.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 154.22999999999999 110.933 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' TRP . . . . . 0.416 ' HA ' ' CE3' ' B' ' 26' ' ' TRP . 0.0 OUTLIER -76.9 -63.86 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 172.63 110.884 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tpp85 -55.46 -51.87 65.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 181.55000000000001 110.883 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.46 -44.16 35.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 169.16999999999999 111.071 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.83 -44.32 66.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 107.23 111.078 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.14 -39.14 97.25 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.774 -0.727 . . . . 121.84999999999999 112.523 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.83 -37.51 64.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.331 . . . . 151.28999999999999 111.081 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.96 -39.88 28.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 166.05000000000001 111.088 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.69 -35.41 68.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 109.18000000000001 110.965 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.29 -46.9 95.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 173.88 111.124 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.15 -59.53 4.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 170.52000000000001 110.963 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.77 -38.59 48.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 103.31999999999999 110.979 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.43 -46.74 94.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 91.799999999999997 111.12 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.05 -62.49 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 109.28 111.047 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -49.06 -32.48 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 150.91 111.131 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mt -58.83 -64.24 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 91.799999999999997 110.92 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.05 -54.14 50.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 91.799999999999997 110.916 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.04 -62.78 1.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 195.78999999999999 111.111 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -49.01 -50.88 26.49 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 121.01000000000001 112.543 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.9 m -49.15 -56.48 9.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.339 . . . . 91.799999999999997 110.888 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -65.0 -35.65 81.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 194.30000000000001 110.991 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.51 -46.49 88.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 112.87 110.945 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.2 -43.38 64.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 146.37 111.115 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -47.96 -58.02 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 91.799999999999997 111.177 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.13 -31.22 5.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 177.37 110.978 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.38 -67.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 95.569999999999993 111.139 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -48.29 -31.36 5.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 135.88 110.957 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.73 -46.2 40.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 170.44 110.92 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.31 45.41 1.31 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 182.78999999999999 112.451 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.72 86.31 7.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 100.03 111.088 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.84 103.46 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.701 2.267 . . . . 91.799999999999997 112.322 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.35 -45.77 0.16 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 91.799999999999997 112.464 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -115.52 158.0 23.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 124.25 111.098 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.74 50.86 1.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 91.799999999999997 111.089 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 mt -122.77 60.25 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 91.799999999999997 110.933 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . . . . . . . . . 4.0 pt -100.65 -31.07 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 102.69 111.158 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -109.21 146.4 34.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 91.799999999999997 110.854 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.456 ' N ' ' CD ' ' B' ' 63' ' ' PRO . 7.7 m-85 -65.71 -47.36 66.41 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 214.80000000000001 111.528 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' B' ' 62' ' ' TYR . 88.0 Cg_exo -46.56 -29.09 7.02 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.028 1.818 . . . . 116.8 112.28 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.49 -45.85 6.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 91.799999999999997 110.817 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.78 -48.98 79.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 91.799999999999997 111.057 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 20.4 mt -48.39 -42.36 31.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 96.650000000000006 110.856 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -36.8 85.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 91.799999999999997 110.868 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -40.52 89.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 91.799999999999997 110.833 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 15.9 m -62.61 -42.92 99.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 91.799999999999997 110.835 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.73 -50.74 65.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 91.799999999999997 111.039 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -62.91 -46.97 85.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 91.799999999999997 110.847 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 8.7 m -59.19 -32.35 69.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 91.799999999999997 110.873 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.36 -30.47 64.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 91.799999999999997 111.136 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 1.4 m -98.22 29.82 3.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 91.799999999999997 111.042 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 51.0 p 47.82 32.62 2.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.329 -0.396 . . . . 91.799999999999997 111.018 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 25.5 t -90.06 -74.73 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 146.59 111.172 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 56.85 70.26 1.03 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.713 -0.756 . . . . 130.62 112.531 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -48.77 -62.11 1.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.323 . . . . 91.799999999999997 110.915 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.63 -28.56 1.9 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.735 -0.745 . . . . 91.799999999999997 112.51 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -48.52 -46.2 38.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.339 . . . . 91.799999999999997 110.878 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 66.5 mt -111.68 106.67 15.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 91.799999999999997 110.944 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -119.87 88.59 40.45 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 101.73 110.908 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.76 132.7 10.41 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.609 2.206 . . . . 91.799999999999997 112.228 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 87.5 t -114.53 -52.14 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 94.209999999999994 111.362 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 22.7 m -54.13 153.15 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.434 -0.348 . . . . 106.2 110.904 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.61 -58.07 5.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 194.88999999999999 110.891 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.13 -58.0 9.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 178.09 110.836 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . -50.09 -44.73 42.55 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.691 -0.766 . . . . 91.799999999999997 112.42 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -69.14 -40.37 78.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 92.120000000000005 110.783 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.23 -40.28 70.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 115.53 110.833 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' VAL . . . . . . . . . . . . . 18.9 t -62.12 -42.53 95.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 91.799999999999997 111.064 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.89 -48.6 69.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 91.799999999999997 111.031 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 23.3 t -66.53 -41.9 89.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 91.799999999999997 111.033 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 65.9 t -63.33 -42.22 95.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 91.799999999999997 111.027 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.55 -31.37 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 91.799999999999997 111.076 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -51.51 64.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 91.799999999999997 110.812 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -60.82 -38.34 78.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 91.799999999999997 111.022 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.97 -46.3 68.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 91.799999999999997 111.087 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.71 -42.49 99.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.765 -0.731 . . . . 91.799999999999997 112.479 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ILE . . . . . 0.449 HG21 HD11 ' B' ' 100' ' ' ILE . 25.1 mt -68.63 -43.76 83.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 101.8 111.081 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' THR . . . . . . . . . . . . . 63.6 m -56.97 -48.38 78.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 91.799999999999997 110.834 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' SER . . . . . . . . . . . . . 15.9 m -63.54 -40.89 98.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 129.13999999999999 110.815 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -70.64 -36.94 73.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 91.799999999999997 110.806 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.73 -51.09 61.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 91.799999999999997 112.486 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 mp -50.85 -34.34 27.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.347 . . . . 91.799999999999997 110.882 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 39.1 t -70.43 -42.88 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 91.799999999999997 110.989 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -62.39 -40.76 97.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 91.799999999999997 110.819 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -78.83 -34.59 45.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 91.799999999999997 111.016 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.92 -46.34 74.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 91.799999999999997 110.989 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 m -63.91 -34.66 69.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 91.799999999999997 111.032 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.71 91.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 102.37 110.948 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.5 -48.36 81.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 129.00999999999999 110.834 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -70.26 -31.52 68.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 165.56999999999999 110.916 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' PHE . . . . . 0.411 ' CD2' ' HA ' ' C' ' 25' ' ' HIS . 3.9 m-30 -62.29 -31.5 72.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 135.15000000000001 110.926 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.79 -30.63 29.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 146.34 111.139 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -88.4 52.44 4.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.743 . . . . 138.06 112.583 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.25 31.05 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.882 0.372 . . . . 115.28 110.96 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.56 -32.79 8.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 227.63999999999999 110.862 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.257 -0.877 . . . . 167.90000000000001 110.924 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.865 0.364 . . . . 185.72 111.049 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 6.9 tp -161.23 -45.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 139.11000000000001 110.878 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' HIS . . . . . 0.411 ' HA ' ' CD2' ' B' ' 114' ' ' PHE . 8.9 p80 -55.9 -31.75 63.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 139.31999999999999 110.895 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.79 -63.9 1.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 190.56999999999999 110.923 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tpp85 -55.38 -51.93 65.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 184.77000000000001 110.911 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.38 -44.19 34.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 172.75 111.122 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.79 -44.33 66.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 113.77 111.118 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.19 -39.14 97.28 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 117.7 112.455 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.77 -37.62 64.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.351 . . . . 157.58000000000001 111.047 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.85 -39.89 27.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 170.66 111.128 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.74 -35.4 68.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 93.459999999999994 110.879 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.3 -46.88 95.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 178.13999999999999 111.153 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.15 -59.6 4.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 157.86000000000001 110.899 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.71 -38.59 48.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 112.92 111.017 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.4 -46.78 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 91.799999999999997 111.131 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.96 -62.53 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 121.53 111.096 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 60.7 t -49.02 -32.49 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 139.06 111.091 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mt -58.83 -64.26 1.0 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 91.799999999999997 110.916 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.1 -54.08 50.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 91.799999999999997 110.897 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.1 -62.73 1.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 191.27000000000001 111.097 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -49.03 -50.88 26.6 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 127.02 112.541 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 5.0 m -49.14 -56.43 9.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.848 0.356 . . . . 91.799999999999997 110.902 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -65.04 -35.66 81.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 202.19999999999999 110.988 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.54 -46.47 88.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 106.63 110.94 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.24 -43.33 64.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 143.47999999999999 111.128 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 t -47.95 -58.02 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 91.799999999999997 111.191 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.21 -31.16 5.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 182.31999999999999 110.995 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.34 -67.9 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 101.59999999999999 111.152 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -48.32 -31.36 5.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 126.81999999999999 110.933 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.82 -46.27 41.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 168.72999999999999 110.931 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -123.0 86.27 0.38 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.715 -0.755 . . . . 179.08000000000001 112.557 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . 172.12 150.69 0.21 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.814 0.34 . . . . 143.78999999999999 111.075 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.41 60.86 5.04 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.69 2.26 . . . . 91.799999999999997 112.334 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.1 -79.66 1.14 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.76 -0.733 . . . . 91.799999999999997 112.514 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.29 -166.33 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.814 0.34 . . . . 121.38 111.094 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.99 -34.24 18.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 91.799999999999997 111.071 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.62 111.02 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 91.799999999999997 110.878 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 pt -139.01 30.78 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 97.340000000000003 111.158 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' SER . . . . . . . . . . . . . 2.1 m -160.76 167.06 27.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 91.799999999999997 110.77 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' TYR . . . . . 0.441 ' N ' ' CD ' ' C' ' 63' ' ' PRO . 1.4 m-85 -78.57 -48.97 1.76 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 155.47999999999999 111.396 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' C' ' 62' ' ' TYR . 77.3 Cg_exo -47.58 -28.19 8.71 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.096 1.864 . . . . 123.81999999999999 112.319 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.21 -45.7 5.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 91.799999999999997 110.854 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.78 -48.98 79.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 91.799999999999997 111.083 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 20.4 mt -48.37 -42.37 31.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 91.799999999999997 110.897 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' TRP . . . . . 0.418 ' CH2' ' HG2' ' D' ' 83' ' ' PRO . 0.0 OUTLIER -64.32 -36.71 85.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 91.799999999999997 110.867 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -40.54 89.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 91.799999999999997 110.894 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' SER . . . . . . . . . . . . . 15.9 m -62.62 -42.9 99.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 91.799999999999997 110.88 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.65 -50.75 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 91.799999999999997 111.077 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -62.99 -46.91 85.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 91.799999999999997 110.828 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 8.7 m -59.26 -32.33 69.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 91.799999999999997 110.873 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.3 -30.56 64.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 91.799999999999997 111.14 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' THR . . . . . . . . . . . . . 1.5 m -97.93 29.48 3.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 91.799999999999997 111.105 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 50.4 p 47.86 32.62 2.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.364 -0.38 . . . . 91.799999999999997 111.024 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' VAL . . . . . . . . . . . . . 25.4 t -90.01 -74.4 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 149.65000000000001 111.131 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' GLY . . . . . . . . . . . . . . . 56.81 69.53 1.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.724 -0.75 . . . . 161.59999999999999 112.509 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' D' ' 82' ' ' TYR . 27.1 m-85 -48.83 -58.05 5.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.833 0.349 . . . . 91.799999999999997 110.98 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' GLY . . . . . 0.404 ' O ' ' CD2' ' C' ' 82' ' ' TYR . . . 136.61 -27.4 2.96 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.661 -0.78 . . . . 91.799999999999997 112.545 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' ASP . . . . . 0.441 ' CB ' ' CZ ' ' D' ' 82' ' ' TYR . 6.1 p-10 -48.16 -31.75 6.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 91.799999999999997 110.977 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' LEU . . . . . . . . . . . . . 56.7 mt -120.49 111.28 17.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 91.799999999999997 110.855 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' C' ' 79' ' ' GLY . 0.1 OUTLIER -121.52 88.93 46.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 100.23 110.959 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.61 122.95 10.46 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.43 2.086 . . . . 91.799999999999997 112.18 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 t -102.57 -40.16 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 91.799999999999997 111.383 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' THR . . . . . . . . . . . . . 59.7 m -50.26 154.92 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 92.040000000000006 110.77 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.32 -58.4 8.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 177.19999999999999 110.89 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.08 -58.11 8.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 201.41999999999999 110.833 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.96 -44.82 41.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.724 -0.75 . . . . 91.799999999999997 112.42 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -69.08 -40.42 78.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 108.14 110.824 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.14 -40.29 70.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 107.02 110.879 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' VAL . . . . . . . . . . . . . 18.8 t -62.16 -42.49 95.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 91.799999999999997 111.096 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.92 -48.58 70.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 91.799999999999997 111.033 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 23.2 t -66.49 -41.94 89.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 91.799999999999997 111.03 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 65.8 t -63.33 -42.19 95.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 91.799999999999997 111.046 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.6 -31.34 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 91.799999999999997 111.1 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -51.54 64.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 91.799999999999997 110.857 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.8 -38.31 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 91.799999999999997 111.028 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.02 -46.31 68.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 91.799999999999997 111.052 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.73 -42.47 99.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 91.799999999999997 112.423 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' ILE . . . . . 0.437 HD11 HG21 ' C' ' 100' ' ' ILE . 25.3 mt -68.66 -43.73 83.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.75 0.309 . . . . 93.269999999999996 111.084 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 63.4 m -57.0 -48.31 78.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 91.799999999999997 110.827 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 15.9 m -63.57 -40.89 98.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 147.09 110.833 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -70.73 -36.84 73.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 91.799999999999997 110.835 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.77 -51.11 60.96 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.737 -0.744 . . . . 91.799999999999997 112.443 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 mp -50.8 -34.35 27.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.357 . . . . 91.799999999999997 110.863 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' VAL . . . . . . . . . . . . . 39.2 t -70.42 -42.86 78.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 91.799999999999997 111.067 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -62.39 -40.75 97.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 91.799999999999997 110.815 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' ALA . . . . . . . . . . . . . . . -78.89 -34.55 44.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 91.799999999999997 110.999 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.91 -46.34 74.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 91.799999999999997 110.986 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' VAL . . . . . 0.4 ' O ' ' CD1' ' C' ' 114' ' ' PHE . 7.0 m -63.88 -34.71 70.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 91.799999999999997 111.022 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.6 -45.63 92.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 108.86 111.035 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.47 -48.41 81.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 131.43000000000001 110.832 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -70.28 -31.46 68.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 166.81999999999999 110.96 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' PHE . . . . . 0.401 ' CD2' ' HA ' ' D' ' 25' ' ' HIS . 3.9 m-30 -62.23 -31.64 72.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 155.75999999999999 110.96 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' VAL . . . . . . . . . . . . . 48.0 t -73.69 -30.63 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 147.30000000000001 111.169 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.82 55.98 4.84 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.749 -0.738 . . . . 141.53999999999999 112.52 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.94 90.71 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 135.47999999999999 110.886 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 7.4 pm0 -98.71 -31.96 11.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 220.34 110.89 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.246 -0.883 . . . . 185.30000000000001 110.913 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 120.838 0.352 . . . . 189.15000000000001 111.055 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 6.9 tp -169.28 -45.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 159.21000000000001 110.897 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' HIS . . . . . 0.401 ' HA ' ' CD2' ' C' ' 114' ' ' PHE . 8.9 p80 -55.89 -31.7 63.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 164.63999999999999 110.913 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' TRP . . . . . 0.414 ' HA ' ' CE3' ' D' ' 26' ' ' TRP . 0.0 OUTLIER -76.88 -63.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 179.06999999999999 110.888 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tpp85 -55.4 -51.89 65.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 187.93000000000001 110.93 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.45 -44.12 35.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 172.16 111.117 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.83 -44.34 66.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 119.26000000000001 111.082 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.2 -39.1 97.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.764 -0.731 . . . . 135.25999999999999 112.492 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.81 -37.55 64.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.823 0.344 . . . . 154.47999999999999 111.099 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.92 -39.85 27.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 169.43000000000001 111.094 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -35.43 68.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 97.060000000000002 110.906 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.2 -47.01 95.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 191.25 111.142 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.12 -59.49 4.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 155.22 110.994 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.81 -38.59 49.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 102.09 110.99 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 38.3 t -63.41 -46.76 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 91.799999999999997 111.115 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' ILE . . . . . . . . . . . . . 68.9 mt -63.98 -62.48 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 116.39 111.079 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' VAL . . . . . . . . . . . . . 60.7 t -49.11 -32.43 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 155.25 111.094 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 mt -58.87 -64.18 1.03 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 91.799999999999997 110.962 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.04 -54.17 49.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 91.799999999999997 110.942 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.06 -62.79 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 199.31999999999999 111.097 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . -49.0 -50.86 26.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.708 -0.758 . . . . 101.55 112.566 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 5.0 m -49.13 -56.39 9.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 91.799999999999997 110.923 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -65.12 -35.65 81.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 201.44 110.923 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.51 -46.5 88.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 127.18000000000001 110.905 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.25 -43.3 64.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 141.66999999999999 111.121 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -48.04 -57.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 91.799999999999997 111.21 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.14 -31.16 5.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 191.44999999999999 111.01 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.43 -67.87 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 100.04000000000001 111.115 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -48.29 -31.42 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 91.799999999999997 110.915 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.79 -46.33 41.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 192.13999999999999 110.913 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.47 66.57 0.26 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.756 -0.735 . . . . 185.63 112.537 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . 172.58 152.51 0.23 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.379 . . . . 117.78 111.11 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.87 90.19 0.03 OUTLIER 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.723 2.282 . . . . 91.799999999999997 112.294 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.41 -170.87 12.52 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.768 -0.73 . . . . 91.799999999999997 112.543 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.62 179.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.859 0.361 . . . . 112.43000000000001 111.097 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.27 74.47 6.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 91.799999999999997 111.174 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.63 -63.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 91.799999999999997 110.797 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 38.2 pt 42.84 32.19 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.934 -0.576 . . . . 109.20999999999999 111.655 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' SER . . . . . . . . . . . . . 2.1 p -177.0 161.16 1.88 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 91.799999999999997 110.928 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' TYR . . . . . 0.444 ' N ' ' CD ' ' D' ' 63' ' ' PRO . 3.5 m-85 -71.73 -47.79 12.02 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 197.03999999999999 111.757 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' D' ' 62' ' ' TYR . 86.1 Cg_exo -45.67 -29.06 5.01 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.156 1.904 . . . . 133.46000000000001 112.452 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.64 -45.78 5.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 91.799999999999997 110.843 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.94 79.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 91.799999999999997 111.1 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' LEU . . . . . . . . . . . . . 20.4 mt -48.44 -42.33 31.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 91.799999999999997 110.844 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' TRP . . . . . 0.415 ' CH2' ' HG2' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -64.32 -36.8 85.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 91.799999999999997 110.821 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -40.52 89.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 91.799999999999997 110.865 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' SER . . . . . . . . . . . . . 16.0 m -62.67 -42.91 99.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 91.799999999999997 110.83 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.64 -50.76 65.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 91.799999999999997 111.12 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -62.93 -46.98 85.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 95.299999999999997 110.819 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 8.7 m -59.2 -32.34 69.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 104.91 110.87 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.41 -30.41 64.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 91.799999999999997 111.141 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' THR . . . . . . . . . . . . . 1.3 m -97.91 29.21 3.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 91.799999999999997 111.047 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' THR . . . . . . . . . . . . . 50.3 p 47.99 32.49 2.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.385 -0.37 . . . . 91.799999999999997 111.012 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' VAL . . . . . . . . . . . . . 24.4 t -89.68 -72.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 163.09999999999999 111.184 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' GLY . . . . . . . . . . . . . . . 56.0 69.91 1.13 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.728 -0.749 . . . . 139.34999999999999 112.447 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -48.64 -57.99 5.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 91.799999999999997 110.947 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' GLY . . . . . . . . . . . . . . . 127.21 -27.48 4.78 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.733 -0.746 . . . . 91.799999999999997 112.594 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -48.06 -31.95 6.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 106.89 110.971 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 3.5 mt -146.41 102.63 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 91.799999999999997 110.88 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' TYR . . . . . 0.441 ' CZ ' ' CB ' ' C' ' 80' ' ' ASP . 30.0 p90 -114.82 150.16 43.61 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 106.70999999999999 110.847 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' PRO . . . . . 0.418 ' HG2' ' CH2' ' C' ' 67' ' ' TRP . 61.3 Cg_endo -73.52 148.29 42.29 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.624 2.216 . . . . 91.799999999999997 112.35 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 45.2 t -127.12 -62.56 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 91.799999999999997 111.089 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' THR . . . . . . . . . . . . . 57.4 m -52.12 160.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 109.83 110.833 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.48 -58.23 7.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 179.58000000000001 110.91 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.18 -58.03 8.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 198.50999999999999 110.818 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . -50.06 -44.77 42.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 91.799999999999997 112.419 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -69.06 -40.41 78.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 100.38 110.827 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.24 -40.27 70.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 116.70999999999999 110.822 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' VAL . . . . . . . . . . . . . 18.8 t -62.16 -42.5 95.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 91.799999999999997 111.049 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.86 -48.62 69.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 91.799999999999997 111.031 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' VAL . . . . . . . . . . . . . 23.3 t -66.49 -41.93 89.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 91.799999999999997 111.035 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 65.8 t -63.32 -42.18 95.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 91.799999999999997 111.086 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.58 -31.4 32.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 91.799999999999997 111.047 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.63 -51.57 64.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 91.799999999999997 110.848 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.85 -38.26 78.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 91.799999999999997 111.039 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.99 -46.37 68.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 91.799999999999997 111.034 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.74 -42.43 99.69 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.75 . . . . 91.799999999999997 112.425 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 100' ' ' ILE . . . . . 0.465 HD13 HG21 ' D' ' 100' ' ' ILE . 25.2 mt -68.65 -43.73 83.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.337 . . . . 114.22 111.098 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 101' ' ' THR . . . . . . . . . . . . . 64.0 m -57.0 -48.3 78.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 91.799999999999997 110.843 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 102' ' ' SER . . . . . . . . . . . . . 15.9 m -63.58 -40.92 98.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 127.73999999999999 110.787 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 103' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -70.65 -36.91 73.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 91.799999999999997 110.831 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.73 -51.11 60.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.747 -0.739 . . . . 94.569999999999993 112.45 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 mp -50.82 -34.36 27.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.841 0.353 . . . . 109.91 110.834 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 106' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.4 -42.88 78.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 91.799999999999997 111.046 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . 0.401 ' CE1' ' HA3' ' A' ' 104' ' ' GLY . 2.9 m-30 -62.41 -40.75 97.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 91.799999999999997 110.777 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 108' ' ' ALA . . . . . . . . . . . . . . . -78.83 -34.63 45.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 91.799999999999997 110.985 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.88 -46.36 74.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 91.799999999999997 111.002 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 m -63.84 -34.78 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 91.799999999999997 111.001 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.52 -45.73 91.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.462 . . . . 122.81 110.998 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 112' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -48.39 81.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 128.65000000000001 110.834 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 113' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -70.27 -31.52 68.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 187.44 110.928 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 114' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -62.25 -31.61 72.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 140.41 110.917 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 115' ' ' VAL . . . . . . . . . . . . . 48.1 t -73.75 -30.78 29.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 154.47 111.174 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.43 57.06 4.94 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.714 -0.755 . . . . 147.03 112.512 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.87 62.06 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.828 0.347 . . . . 129.09 110.886 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -31.72 73.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 219.72 110.923 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 119' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.246 -0.883 . . . . 171.94 110.904 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 801' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.819 0.342 . . . . 20.0 111.583 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 802' ' ' PHE . . . . . 0.418 ' CE1' ' HD3' ' E' ' 834' ' ' ARG . 9.5 m-85 -122.75 104.3 9.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 20.0 110.831 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 803' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.03 -178.72 3.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 20.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 804' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -80.53 75.24 7.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 20.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 805' ' ' VAL . . . . . . . . . . . . . 93.7 t -109.11 129.62 63.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 20.0 111.17 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 806' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.66 159.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 20.0 110.87 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 807' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.73 110.01 11.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 20.0 110.899 -179.949 -117.673 -46.451 -135.565 103.796 2.029 103.79 -50.676 -132.955 2 2 . 1 . 001 nuclear orig full ' E' E ' 808' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.11 -48.59 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 20.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 809' ' ' THR . . . . . . . . . . . . . 2.4 m -143.0 164.32 30.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 20.0 110.86 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 810' ' ' SER . . . . . . . . . . . . . 25.6 p -85.63 -38.75 18.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 20.0 110.909 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 811' ' ' LYS . . . . . 0.417 ' HA ' ' CZ3' ' E' ' 814' ' ' TRP . 17.5 mttp -56.51 -34.52 67.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 20.0 110.955 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 812' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.04 -32.41 21.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 20.0 110.952 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 813' ' ' CYS . . . . . . . . . . . . . 1.1 m -52.5 -31.69 36.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 20.0 110.876 -179.994 -99.572 -97.088 152.062 103.789 2.03 103.786 137.128 -177.327 1 1 . 1 . 001 nuclear orig full ' E' E ' 814' ' ' TRP . . . . . 0.417 ' CZ3' ' HA ' ' E' ' 811' ' ' LYS . 1.8 m0 -73.5 -53.0 11.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 20.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 815' ' ' SER . . . . . . . . . . . . . 4.4 m -50.41 -33.7 21.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 20.0 110.917 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 816' ' ' VAL . . . . . . . . . . . . . 57.9 t -71.49 -42.05 72.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 20.0 111.087 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 817' ' ' CYS . . . . . . . . . . . . . 86.5 m -61.73 -48.21 81.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 20.0 110.884 179.996 -67.803 -55.612 -102.458 103.851 2.029 103.831 -60.518 -78.195 1 1 . 1 . 001 nuclear orig full ' E' E ' 818' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -62.13 -36.65 82.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 20.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 819' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -45.42 56.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 20.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 820' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.85 -66.8 0.39 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 20.0 110.942 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 821' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.09 -76.9 0.57 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 20.0 110.918 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 822' ' ' ASN . . . . . . . . . . . . . 2.8 p30 171.45 48.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 20.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 823' ' ' THR . . . . . . . . . . . . . 51.2 p -136.25 173.3 11.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 20.0 110.909 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 824' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.55 -178.2 6.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 20.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 825' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? 57.97 104.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 20.0 110.907 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 826' ' ' GLY . . . . . . . . . . . . . . . -164.52 128.42 1.8 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.742 -0.742 . . . . 20.0 112.512 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 827' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.73 166.61 6.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.848 0.356 . . . . 20.0 110.857 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 828' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.43 129.6 55.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 20.0 110.876 -179.999 -132.955 -50.676 -135.565 103.79 2.029 103.796 -46.451 -117.673 2 2 . 1 . 001 nuclear orig full ' E' E ' 829' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.8 147.74 29.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 20.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 830' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -48.68 -31.63 7.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 20.0 110.917 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 831' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.32 -69.35 0.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 20.0 110.9 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 832' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.94 146.47 25.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 20.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 833' ' ' CYS . . . . . . . . . . . . . 47.5 t -59.8 130.21 45.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 20.0 110.869 -179.981 -177.327 137.128 152.062 103.786 2.03 103.789 -97.088 -99.572 1 1 . 1 . 001 nuclear orig full ' E' E ' 834' ' ' ARG . . . . . 0.418 ' HD3' ' CE1' ' E' ' 802' ' ' PHE . 91.1 mtt180 -99.12 136.56 38.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 20.0 110.941 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 835' ' ' CYS . . . . . . . . . . . . . 33.9 m -92.1 144.52 25.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 20.0 110.816 -179.971 -78.195 -60.518 -102.458 103.831 2.029 103.851 -55.612 -67.803 1 1 . 1 . 001 nuclear orig full ' E' E ' 836' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.01 178.23 7.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 20.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 837' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.201 -0.904 . . . . 20.0 110.862 -179.991 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.817 0.341 . . . . 181.62 111.047 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.851 HD22 ' HD2' ' D' ' 117' ' ' ARG . 6.9 tp -177.23 -44.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 163.38999999999999 110.955 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -55.92 -31.73 63.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 154.91999999999999 110.93 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.406 ' CE3' ' HA ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -76.84 -63.93 1.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 178.34 110.882 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tpp85 -55.43 -51.91 65.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 182.99000000000001 110.9 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.418 ' HB1' HD23 ' A' ' 105' ' ' LEU . . . -48.37 -44.21 34.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 172.56 111.109 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.634 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . . . -70.79 -44.34 66.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 108.12 111.12 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.16 -39.13 97.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.691 -0.766 . . . . 114.36 112.528 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.74 -37.59 65.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.822 0.344 . . . . 156.87 111.106 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.873 ' HB1' ' HA ' ' A' ' 102' ' ' SER . . . -48.86 -39.89 27.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 168.03 111.091 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.75 -35.41 68.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 124.14 110.876 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.24 -46.92 95.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 186.53 111.144 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -52.17 -59.52 4.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 143.06 110.958 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.715 HD12 ' HA2' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -50.72 -38.62 48.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 121.26000000000001 110.979 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.628 ' N ' HD23 ' A' ' 36' ' ' LEU . 38.1 t -63.47 -46.72 94.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 66.030000000000001 111.084 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.1 mt -63.96 -62.55 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 116.76000000000001 111.05 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -49.15 -32.35 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 140.44 111.099 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 70' ' ' VAL . 5.4 mt -58.9 -64.18 1.03 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 56.439999999999998 110.921 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.532 HD12 ' O ' ' A' ' 37' ' ' VAL . 0.9 OUTLIER -57.17 -54.05 51.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 60.810000000000002 110.937 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.04 -62.79 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 201.16 111.099 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -49.05 -50.84 26.79 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.666 -0.778 . . . . 121.73 112.549 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.0 m -49.14 -56.37 9.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 75.75 110.956 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -65.11 -35.61 81.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 207.41 110.934 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.61 -46.44 88.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 119.83 110.864 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.759 ' HB2' HG21 ' A' ' 91' ' ' VAL . . . -72.28 -43.29 64.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 146.28 111.125 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.675 HG11 ' CE1' ' A' ' 62' ' ' TYR . 2.5 t -48.02 -58.01 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 103.3 111.183 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.17 -31.14 5.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 186.56999999999999 111.002 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.38 -67.9 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 91.450000000000003 111.149 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -48.24 -31.44 5.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 140.74000000000001 110.919 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.431 ' HA ' HG22 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -48.66 -46.26 39.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 184.00999999999999 110.925 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.0 49.84 0.82 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.702 -0.761 . . . . 183.50999999999999 112.506 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.619 ' HB1' ' HD2' ' A' ' 55' ' ' PRO . . . -157.9 161.99 27.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 129.59999999999999 111.141 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.619 ' HD2' ' HB1' ' A' ' 54' ' ' ALA . 53.6 Cg_endo -69.74 87.31 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.752 2.301 . . . . 74.930000000000007 112.314 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -125.12 -172.9 13.56 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.739 -0.743 . . . . 60.75 112.5 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.96 -70.53 0.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 121.54000000000001 111.088 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -163.89 31.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.137 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.755 HD22 ' CE3' ' A' ' 68' ' ' TRP . 29.7 mt -92.98 50.88 1.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 89.299999999999997 110.863 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 48' ' ' VAL . 19.4 pt -96.58 -32.21 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 97.340000000000003 111.145 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.09 156.25 24.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.85 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.675 ' CE1' HG11 ' A' ' 48' ' ' VAL . 4.9 m-85 -69.78 -47.54 23.86 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 185.28 111.57 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 62' ' ' TYR . 87.6 Cg_exo -46.51 -28.92 6.71 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.102 1.868 . . . . 106.64 112.266 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.41 -45.84 5.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.8 -48.91 79.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 93.680000000000007 111.115 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.3 mt -48.4 -42.37 31.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 73.790000000000006 110.876 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -36.75 85.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 92.480000000000004 110.836 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.755 ' CE3' HD22 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -66.54 -40.55 89.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 65.099999999999994 110.856 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.9 m -62.63 -42.89 99.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 60.159999999999997 110.868 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.634 ' HA ' HD21 ' A' ' 40' ' ' LEU . 40.3 t -55.71 -50.71 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 40.960000000000001 111.033 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.451 ' OE1' HG11 ' A' ' 76' ' ' VAL . 62.7 mm-40 -63.0 -46.89 85.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 91.799999999999997 110.837 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.446 HG22 ' HG3' ' A' ' 96' ' ' MET . 9.1 m -59.25 -32.28 69.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 93.489999999999995 110.853 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.36 -30.51 64.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 78.090000000000003 111.144 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.489 HG22 HD11 ' B' ' 100' ' ' ILE . 1.5 m -98.17 29.64 3.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 80.409999999999997 111.067 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 50.1 p 47.94 32.59 2.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.347 -0.388 . . . . 78.569999999999993 110.994 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.451 HG11 ' OE1' ' A' ' 71' ' ' GLU . 25.6 t -90.54 -74.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 146.84999999999999 111.108 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.443 ' N ' HG12 ' A' ' 76' ' ' VAL . . . 56.53 69.89 1.14 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.698 -0.763 . . . . 148.34 112.485 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -48.54 -56.84 7.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 62.829999999999998 110.929 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.45 -31.96 2.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.742 -0.742 . . . . 72.420000000000002 112.502 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -50.54 -52.47 38.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.836 0.35 . . . . 83.319999999999993 110.894 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.77 101.45 9.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 85.939999999999998 110.882 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -125.21 150.8 68.2 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 98.819999999999993 110.912 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.435 ' HG2' ' CH2' ' D' ' 67' ' ' TRP . 66.5 Cg_endo -74.51 159.67 42.65 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.648 2.232 . . . . 90.409999999999997 112.341 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.6 t -139.31 -48.28 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 83.590000000000003 111.035 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 86' ' ' LEU . 99.3 m -74.41 160.11 31.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 97.150000000000006 110.797 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.479 ' N ' HG22 ' A' ' 85' ' ' THR . 0.2 OUTLIER -48.48 -58.25 4.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.418 . . . . 182.22999999999999 110.878 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.14 -58.02 8.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 203.72999999999999 110.863 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.417 ' HA2' ' HB1' ' A' ' 47' ' ' ALA . . . -50.07 -44.74 42.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.69 -0.767 . . . . 60.439999999999998 112.382 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -69.17 -40.32 78.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 90.5 110.78 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.716 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -55.29 -40.25 70.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 123.86 110.818 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.759 HG21 ' HB2' ' A' ' 47' ' ' ALA . 18.7 t -62.16 -42.48 95.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 56.740000000000002 111.081 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.84 -48.69 69.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 74.349999999999994 111.049 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.0 t -66.39 -41.97 89.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.487 . . . . 85.019999999999996 111.099 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 90' ' ' CYS . 65.8 t -63.34 -42.14 95.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 50.560000000000002 111.089 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.57 -31.37 32.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 74.969999999999999 111.13 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.446 ' HG3' HG22 ' A' ' 72' ' ' THR . 0.1 OUTLIER -63.75 -51.45 64.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 87.140000000000001 110.858 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.87 -38.35 78.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 79.790000000000006 110.976 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.98 -46.36 68.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 43.539999999999999 111.004 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.715 ' HA2' HD12 ' A' ' 36' ' ' LEU . . . -62.72 -42.47 99.68 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.742 -0.742 . . . . 51.0 112.441 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.546 HD11 HG22 ' D' ' 74' ' ' THR . 25.3 mt -68.62 -43.8 83.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.348 . . . . 93.590000000000003 111.07 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.447 ' O ' HD12 ' A' ' 105' ' ' LEU . 63.8 m -56.97 -48.31 78.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 73.959999999999994 110.853 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.873 ' HA ' ' HB1' ' A' ' 32' ' ' ALA . 15.8 m -63.57 -40.9 98.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 133.81999999999999 110.862 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.62 -36.89 73.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' D' ' 107' ' ' PHE . . . -59.74 -51.15 60.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 93.930000000000007 112.43 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.654 HD22 ' HB2' ' A' ' 32' ' ' ALA . 3.2 mp -50.8 -34.38 27.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.341 . . . . 93.930000000000007 110.819 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 102' ' ' SER . 39.1 t -70.4 -42.86 78.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 46.850000000000001 111.014 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.408 ' CE1' ' HA3' ' B' ' 104' ' ' GLY . 2.9 m-30 -62.38 -40.8 97.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.782 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -78.8 -34.64 45.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 84.840000000000003 110.991 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.634 ' HB2' ' HB2' ' A' ' 29' ' ' ALA . . . -54.93 -46.32 74.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 66.900000000000006 111.011 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.514 HG23 ' CB ' ' B' ' 108' ' ' ALA . 7.0 m -63.89 -34.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.056 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.603 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -62.56 -45.61 92.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 102.69 111.054 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.419 HG23 HG22 ' D' ' 115' ' ' VAL . 0.1 OUTLIER -59.54 -48.34 82.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 140.03 110.854 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.438 ' CZ2' HD21 ' B' ' 24' ' ' LEU . 9.0 t90 -70.3 -31.5 68.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.472 . . . . 183.49000000000001 110.869 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' B' ' 25' ' ' HIS . 3.8 m-30 -62.34 -31.5 72.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 127.13 110.909 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 111' ' ' ALA . 48.1 t -73.79 -30.65 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 156.63 111.177 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -93.1 66.07 1.87 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.713 -0.756 . . . . 125.69 112.54 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.615 ' HG3' HD22 ' B' ' 24' ' ' LEU . 0.1 OUTLIER -165.99 37.27 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 119.23999999999999 110.911 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -48.47 -46.13 37.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 217.47999999999999 110.87 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.206 -0.902 . . . . 193.75 110.867 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.785 0.326 . . . . 173.56999999999999 111.057 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.615 HD22 ' HG3' ' A' ' 117' ' ' ARG . 7.0 tp -177.52 -44.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 159.27000000000001 110.873 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' HIS . . . . . 0.415 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 8.9 p80 -55.96 -31.68 63.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 154.22999999999999 110.933 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' TRP . . . . . 0.418 ' HA ' ' CE3' ' B' ' 26' ' ' TRP . 0.0 OUTLIER -76.9 -63.86 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 172.63 110.884 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tpp85 -55.46 -51.87 65.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 181.55000000000001 110.883 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.415 ' HB1' HD23 ' B' ' 105' ' ' LEU . . . -48.46 -44.16 35.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 169.16999999999999 111.071 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' B' ' 109' ' ' ALA . . . -70.83 -44.32 66.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 107.23 111.078 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.14 -39.14 97.25 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.774 -0.727 . . . . 121.84999999999999 112.523 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.83 -37.51 64.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.331 . . . . 151.28999999999999 111.081 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ALA . . . . . 0.883 ' HB1' ' HA ' ' B' ' 102' ' ' SER . . . -48.96 -39.88 28.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 166.05000000000001 111.088 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.69 -35.41 68.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 109.18000000000001 110.965 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.29 -46.9 95.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 173.88 111.124 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' B' ' 32' ' ' ALA . 1.0 OUTLIER -52.15 -59.53 4.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 170.52000000000001 110.963 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.704 HD12 ' HA2' ' B' ' 99' ' ' GLY . 0.1 OUTLIER -50.77 -38.59 48.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 103.31999999999999 110.979 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.633 ' N ' HD23 ' B' ' 36' ' ' LEU . 38.2 t -63.43 -46.74 94.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 85.209999999999994 111.12 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.05 -62.49 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 109.28 111.047 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -49.06 -32.48 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 150.91 111.131 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' B' ' 70' ' ' VAL . 5.4 mt -58.83 -64.24 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 64.790000000000006 110.92 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.529 HD12 ' O ' ' B' ' 37' ' ' VAL . 0.9 OUTLIER -57.05 -54.14 50.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 61.75 110.916 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.04 -62.78 1.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 195.78999999999999 111.111 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -49.01 -50.88 26.49 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 121.01000000000001 112.543 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.9 m -49.15 -56.48 9.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.339 . . . . 82.010000000000005 110.888 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -65.0 -35.65 81.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 194.30000000000001 110.991 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.51 -46.49 88.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 112.87 110.945 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.757 ' HB2' HG21 ' B' ' 91' ' ' VAL . . . -72.2 -43.38 64.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 146.37 111.115 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.646 HG11 ' CE1' ' B' ' 62' ' ' TYR . 2.5 t -47.96 -58.02 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 68.980000000000004 111.177 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.13 -31.22 5.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 177.37 110.978 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.38 -67.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 95.569999999999993 111.139 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -48.29 -31.36 5.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 135.88 110.957 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.654 ' HA ' HG22 ' B' ' 60' ' ' ILE . 0.2 OUTLIER -48.73 -46.2 40.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 170.44 110.92 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.31 45.41 1.31 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 182.78999999999999 112.451 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.72 86.31 7.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 100.03 111.088 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.84 103.46 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.701 2.267 . . . . 91.329999999999998 112.322 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.35 -45.77 0.16 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 41.719999999999999 112.464 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -115.52 158.0 23.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 124.25 111.098 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.603 ' HB3' HD23 ' B' ' 81' ' ' LEU . . . -95.74 50.86 1.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.089 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.693 HD21 ' HB3' ' B' ' 81' ' ' LEU . 1.9 mt -122.77 60.25 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 71.349999999999994 110.933 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.654 HG22 ' HA ' ' B' ' 52' ' ' ARG . 4.0 pt -100.65 -31.07 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 102.69 111.158 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -109.21 146.4 34.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.646 ' CE1' HG11 ' B' ' 48' ' ' VAL . 7.7 m-85 -65.71 -47.36 66.41 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 214.80000000000001 111.528 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' B' ' 62' ' ' TYR . 88.0 Cg_exo -46.56 -29.09 7.02 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.028 1.818 . . . . 116.8 112.28 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.49 -45.85 6.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.78 -48.98 79.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 90.909999999999997 111.057 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 20.4 mt -48.39 -42.36 31.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 96.650000000000006 110.856 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -36.8 85.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 81.170000000000002 110.868 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' TRP . . . . . 0.576 ' CE3' HD22 ' B' ' 59' ' ' LEU . 0.0 OUTLIER -66.56 -40.52 89.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 58.82 110.833 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.408 ' HB3' HG21 ' B' ' 95' ' ' VAL . 15.9 m -62.61 -42.92 99.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 68.840000000000003 110.835 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.625 ' HA ' HD21 ' B' ' 40' ' ' LEU . 40.3 t -55.73 -50.74 65.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 33.399999999999999 111.039 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.439 ' OE1' HG11 ' B' ' 76' ' ' VAL . 62.7 mm-40 -62.91 -46.97 85.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 91.799999999999997 110.847 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' THR . . . . . 0.442 HG22 ' HG3' ' B' ' 96' ' ' MET . 8.7 m -59.19 -32.35 69.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 90.469999999999999 110.873 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.36 -30.47 64.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 58.829999999999998 111.136 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.464 HG22 HD11 ' C' ' 100' ' ' ILE . 1.4 m -98.22 29.82 3.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 49.689999999999998 111.042 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 51.0 p 47.82 32.62 2.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.329 -0.396 . . . . 73.540000000000006 111.018 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.448 HG12 ' N ' ' B' ' 77' ' ' GLY . 25.5 t -90.06 -74.73 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 146.59 111.172 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' GLY . . . . . 0.448 ' N ' HG12 ' B' ' 76' ' ' VAL . . . 56.85 70.26 1.03 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.713 -0.756 . . . . 130.62 112.531 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -48.77 -62.11 1.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.323 . . . . 53.280000000000001 110.915 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.63 -28.56 1.9 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.735 -0.745 . . . . 41.450000000000003 112.51 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -48.52 -46.2 38.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.339 . . . . 58.149999999999999 110.878 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.693 ' HB3' HD21 ' B' ' 59' ' ' LEU . 66.5 mt -111.68 106.67 15.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 60.810000000000002 110.944 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -119.87 88.59 40.45 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 101.73 110.908 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.76 132.7 10.41 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.609 2.206 . . . . 65.609999999999999 112.228 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 87.5 t -114.53 -52.14 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 94.209999999999994 111.362 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 22.7 m -54.13 153.15 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.434 -0.348 . . . . 106.2 110.904 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.61 -58.07 5.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 194.88999999999999 110.891 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.13 -58.0 9.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 178.09 110.836 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.407 ' HA2' ' HB1' ' B' ' 47' ' ' ALA . . . -50.09 -44.73 42.55 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.691 -0.766 . . . . 49.939999999999998 112.42 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -69.14 -40.37 78.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 92.120000000000005 110.783 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' CYS . . . . . 0.72 ' O ' HG23 ' B' ' 94' ' ' VAL . 0.1 OUTLIER -55.23 -40.28 70.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 115.53 110.833 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 91' ' ' VAL . . . . . 0.757 HG21 ' HB2' ' B' ' 47' ' ' ALA . 18.9 t -62.12 -42.53 95.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 33.460000000000001 111.064 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.89 -48.6 69.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 77.480000000000004 111.031 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 23.3 t -66.53 -41.9 89.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 83.079999999999998 111.033 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.72 HG23 ' O ' ' B' ' 90' ' ' CYS . 65.9 t -63.33 -42.22 95.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 45.5 111.027 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' VAL . . . . . 0.408 HG21 ' HB3' ' B' ' 69' ' ' SER . 0.3 OUTLIER -73.55 -31.37 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 65.459999999999994 111.076 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 96' ' ' MET . . . . . 0.442 ' HG3' HG22 ' B' ' 72' ' ' THR . 0.1 OUTLIER -63.76 -51.51 64.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 69.599999999999994 110.812 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -60.82 -38.34 78.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 83.359999999999999 111.022 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.97 -46.3 68.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 38.060000000000002 111.087 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLY . . . . . 0.704 ' HA2' HD12 ' B' ' 36' ' ' LEU . . . -62.71 -42.49 99.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.765 -0.731 . . . . 42.710000000000001 112.479 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 74' ' ' THR . 25.1 mt -68.63 -43.76 83.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 101.8 111.081 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' THR . . . . . 0.449 ' O ' HD12 ' B' ' 105' ' ' LEU . 63.6 m -56.97 -48.38 78.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 40.710000000000001 110.834 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' SER . . . . . 0.883 ' HA ' ' HB1' ' B' ' 32' ' ' ALA . 15.9 m -63.54 -40.89 98.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 129.13999999999999 110.815 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -70.64 -36.94 73.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' GLY . . . . . 0.408 ' HA3' ' CE1' ' A' ' 107' ' ' PHE . . . -59.73 -51.09 61.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 89.200000000000003 112.486 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.661 HD22 ' HB2' ' B' ' 32' ' ' ALA . 3.2 mp -50.85 -34.34 27.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.347 . . . . 76.560000000000002 110.882 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' VAL . . . . . 0.408 HG23 ' O ' ' B' ' 102' ' ' SER . 39.1 t -70.43 -42.88 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 51.359999999999999 110.989 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.404 ' CE1' ' HA3' ' C' ' 104' ' ' GLY . 2.9 m-30 -62.39 -40.76 97.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.819 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ALA . . . . . 0.514 ' CB ' HG23 ' A' ' 110' ' ' VAL . . . -78.83 -34.59 45.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 76.840000000000003 111.016 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' B' ' 29' ' ' ALA . . . -54.92 -46.34 74.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 64.819999999999993 110.989 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' VAL . . . . . 0.497 HG23 ' CB ' ' C' ' 108' ' ' ALA . 7.0 m -63.91 -34.66 69.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.032 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.591 ' O ' HG23 ' B' ' 115' ' ' VAL . . . -62.56 -45.71 91.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 102.37 110.948 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.488 HG23 HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -59.5 -48.36 81.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 129.00999999999999 110.834 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 113' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -70.26 -31.52 68.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 165.56999999999999 110.916 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' PHE . . . . . 0.42 ' CD2' ' HA ' ' C' ' 25' ' ' HIS . 3.9 m-30 -62.29 -31.5 72.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 135.15000000000001 110.926 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.591 HG23 ' O ' ' B' ' 111' ' ' ALA . 48.2 t -73.79 -30.63 29.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 146.34 111.139 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -88.4 52.44 4.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.743 . . . . 138.06 112.583 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' ARG . . . . . 0.495 ' HG3' HD22 ' C' ' 24' ' ' LEU . 0.0 OUTLIER -163.25 31.05 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.882 0.372 . . . . 115.28 110.96 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.56 -32.79 8.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 227.63999999999999 110.862 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.257 -0.877 . . . . 167.90000000000001 110.924 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.865 0.364 . . . . 185.72 111.049 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.495 HD22 ' HG3' ' B' ' 117' ' ' ARG . 6.9 tp -161.23 -45.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 139.11000000000001 110.878 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 25' ' ' HIS . . . . . 0.42 ' HA ' ' CD2' ' B' ' 114' ' ' PHE . 8.9 p80 -55.9 -31.75 63.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 139.31999999999999 110.895 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 26' ' ' TRP . . . . . 0.4 ' CE3' ' HA ' ' C' ' 26' ' ' TRP . 0.0 OUTLIER -76.79 -63.9 1.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 190.56999999999999 110.923 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tpp85 -55.38 -51.93 65.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 184.77000000000001 110.911 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.418 ' HB1' HD23 ' C' ' 105' ' ' LEU . . . -48.38 -44.19 34.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 172.75 111.122 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.635 ' HB2' ' HB2' ' C' ' 109' ' ' ALA . . . -70.79 -44.33 66.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 113.77 111.118 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.19 -39.14 97.28 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 117.7 112.455 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.77 -37.62 64.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.351 . . . . 157.58000000000001 111.047 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.878 ' HB1' ' HA ' ' C' ' 102' ' ' SER . . . -48.85 -39.89 27.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 170.66 111.128 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.74 -35.4 68.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 93.459999999999994 110.879 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 34' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.3 -46.88 95.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 178.13999999999999 111.153 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' C' ' 32' ' ' ALA . 1.0 OUTLIER -52.15 -59.6 4.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 157.86000000000001 110.899 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.719 HD12 ' HA2' ' C' ' 99' ' ' GLY . 0.1 OUTLIER -50.71 -38.59 48.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 112.92 111.017 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.636 ' N ' HD23 ' C' ' 36' ' ' LEU . 38.2 t -63.4 -46.78 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 80.260000000000005 111.131 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 38' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.96 -62.53 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 121.53 111.096 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 60.7 t -49.02 -32.49 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 139.06 111.091 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.626 HD21 ' HA ' ' C' ' 70' ' ' VAL . 5.4 mt -58.83 -64.26 1.0 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 48.090000000000003 110.916 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 41' ' ' LEU . . . . . 0.527 HD12 ' O ' ' C' ' 37' ' ' VAL . 0.9 OUTLIER -57.1 -54.08 50.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 67.049999999999997 110.897 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.1 -62.73 1.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 191.27000000000001 111.097 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -49.03 -50.88 26.6 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 127.02 112.541 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 5.0 m -49.14 -56.43 9.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.848 0.356 . . . . 63.119999999999997 110.902 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -65.04 -35.66 81.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 202.19999999999999 110.988 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.54 -46.47 88.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 106.63 110.94 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.746 ' HB2' HG21 ' C' ' 91' ' ' VAL . . . -72.24 -43.33 64.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 143.47999999999999 111.128 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 48' ' ' VAL . . . . . 0.5 HG11 ' CE1' ' C' ' 62' ' ' TYR . 2.6 t -47.95 -58.02 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 83.709999999999994 111.191 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.21 -31.16 5.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 182.31999999999999 110.995 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.34 -67.9 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 101.59999999999999 111.152 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' GLU . . . . . 0.58 ' HG3' HD11 ' C' ' 59' ' ' LEU . 11.7 mm-40 -48.32 -31.36 5.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 126.81999999999999 110.933 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.66 ' HA ' HG22 ' C' ' 60' ' ' ILE . 0.2 OUTLIER -48.82 -46.27 41.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 168.72999999999999 110.931 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 53' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' C' ' 54' ' ' ALA . . . -123.0 86.27 0.38 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.715 -0.755 . . . . 179.08000000000001 112.557 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 54' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' C' ' 53' ' ' GLY . . . 172.12 150.69 0.21 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.814 0.34 . . . . 143.78999999999999 111.075 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.41 60.86 5.04 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.69 2.26 . . . . 70.989999999999995 112.334 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.1 -79.66 1.14 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.76 -0.733 . . . . 45.119999999999997 112.514 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' C' ' 82' ' ' TYR . . . -134.29 -166.33 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.814 0.34 . . . . 121.38 111.094 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.99 -34.24 18.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.071 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.58 HD11 ' HG3' ' C' ' 51' ' ' GLU . 0.5 OUTLIER -49.62 111.02 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 53.5 110.878 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.66 HG22 ' HA ' ' C' ' 52' ' ' ARG . 3.0 pt -139.01 30.78 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 97.340000000000003 111.158 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 61' ' ' SER . . . . . . . . . . . . . 2.1 m -160.76 167.06 27.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.77 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' TYR . . . . . 0.5 ' CE1' HG11 ' C' ' 48' ' ' VAL . 1.4 m-85 -78.57 -48.97 1.76 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 155.47999999999999 111.396 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 63' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' C' ' 62' ' ' TYR . 77.3 Cg_exo -47.58 -28.19 8.71 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.096 1.864 . . . . 123.81999999999999 112.319 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.21 -45.7 5.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.78 -48.98 79.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 82.719999999999999 111.083 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 20.4 mt -48.37 -42.37 31.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 91.340000000000003 110.897 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' TRP . . . . . 0.43 ' CH2' ' HG2' ' D' ' 83' ' ' PRO . 0.0 OUTLIER -64.32 -36.71 85.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 77.069999999999993 110.867 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 68' ' ' TRP . . . . . 0.679 ' HB2' HD12 ' C' ' 81' ' ' LEU . 0.0 OUTLIER -66.54 -40.54 89.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 53.259999999999998 110.894 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 69' ' ' SER . . . . . 0.402 ' HB3' HG21 ' C' ' 95' ' ' VAL . 15.9 m -62.62 -42.9 99.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 83.469999999999999 110.88 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.626 ' HA ' HD21 ' C' ' 40' ' ' LEU . 40.4 t -55.65 -50.75 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 35.369999999999997 111.077 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.446 ' OE1' HG11 ' C' ' 76' ' ' VAL . 62.7 mm-40 -62.99 -46.91 85.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 91.799999999999997 110.828 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 72' ' ' THR . . . . . 0.438 HG22 ' HG3' ' C' ' 96' ' ' MET . 8.7 m -59.26 -32.33 69.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 84.25 110.873 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.3 -30.56 64.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 67.969999999999999 111.14 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 74' ' ' THR . . . . . 0.511 HG22 HD11 ' D' ' 100' ' ' ILE . 1.5 m -97.93 29.48 3.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 23.629999999999999 111.105 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 50.4 p 47.86 32.62 2.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.364 -0.38 . . . . 65.209999999999994 111.024 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 76' ' ' VAL . . . . . 0.446 HG11 ' OE1' ' C' ' 71' ' ' GLU . 25.4 t -90.01 -74.4 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 149.65000000000001 111.131 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 77' ' ' GLY . . . . . 0.442 ' N ' HG12 ' C' ' 76' ' ' VAL . . . 56.81 69.53 1.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.724 -0.75 . . . . 161.59999999999999 112.509 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 78' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' D' ' 82' ' ' TYR . 27.1 m-85 -48.83 -58.05 5.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.833 0.349 . . . . 80.0 110.98 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 79' ' ' GLY . . . . . 0.404 ' O ' ' CD2' ' C' ' 82' ' ' TYR . . . 136.61 -27.4 2.96 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.661 -0.78 . . . . 74.909999999999997 112.545 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 80' ' ' ASP . . . . . 0.441 ' CB ' ' CZ ' ' D' ' 82' ' ' TYR . 6.1 p-10 -48.16 -31.75 6.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 67.599999999999994 110.977 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 81' ' ' LEU . . . . . 0.679 HD12 ' HB2' ' C' ' 68' ' ' TRP . 56.7 mt -120.49 111.28 17.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 75.989999999999995 110.855 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 82' ' ' TYR . . . . . 0.449 ' O ' ' HB2' ' C' ' 57' ' ' ALA . 0.1 OUTLIER -121.52 88.93 46.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 100.23 110.959 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 83' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.61 122.95 10.46 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.43 2.086 . . . . 85.790000000000006 112.18 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 t -102.57 -40.16 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 72.849999999999994 111.383 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 85' ' ' THR . . . . . . . . . . . . . 59.7 m -50.26 154.92 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 92.040000000000006 110.77 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.32 -58.4 8.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 177.19999999999999 110.89 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 87' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.08 -58.11 8.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 201.41999999999999 110.833 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 88' ' ' GLY . . . . . 0.416 ' HA2' ' HB1' ' C' ' 47' ' ' ALA . . . -49.96 -44.82 41.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.724 -0.75 . . . . 64.219999999999999 112.42 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 89' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -69.08 -40.42 78.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 108.14 110.824 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' CYS . . . . . 0.721 ' O ' HG23 ' C' ' 94' ' ' VAL . 0.1 OUTLIER -55.14 -40.29 70.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 107.02 110.879 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 91' ' ' VAL . . . . . 0.746 HG21 ' HB2' ' C' ' 47' ' ' ALA . 18.8 t -62.16 -42.49 95.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 51.75 111.096 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.92 -48.58 70.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 82.859999999999999 111.033 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.424 HG22 HG11 ' B' ' 70' ' ' VAL . 23.2 t -66.49 -41.94 89.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 54.670000000000002 111.03 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.721 HG23 ' O ' ' C' ' 90' ' ' CYS . 65.8 t -63.33 -42.19 95.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 44.259999999999998 111.046 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 95' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' C' ' 69' ' ' SER . 0.3 OUTLIER -73.6 -31.34 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 63.710000000000001 111.1 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 96' ' ' MET . . . . . 0.438 ' HG3' HG22 ' C' ' 72' ' ' THR . 0.1 OUTLIER -63.72 -51.54 64.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 90.799999999999997 110.857 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.8 -38.31 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 46.299999999999997 111.028 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.02 -46.31 68.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 52.090000000000003 111.052 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 99' ' ' GLY . . . . . 0.719 ' HA2' HD12 ' C' ' 36' ' ' LEU . . . -62.73 -42.47 99.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 20.59 112.423 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 100' ' ' ILE . . . . . 0.464 HD11 HG22 ' B' ' 74' ' ' THR . 25.3 mt -68.66 -43.73 83.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.75 0.309 . . . . 93.269999999999996 111.084 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 101' ' ' THR . . . . . 0.448 ' O ' HD12 ' C' ' 105' ' ' LEU . 63.4 m -57.0 -48.31 78.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 38.859999999999999 110.827 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 102' ' ' SER . . . . . 0.878 ' HA ' ' HB1' ' C' ' 32' ' ' ALA . 15.9 m -63.57 -40.89 98.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 147.09 110.833 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 103' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -70.73 -36.84 73.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.835 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 104' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' B' ' 107' ' ' PHE . . . -59.77 -51.11 60.96 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.737 -0.744 . . . . 65.900000000000006 112.443 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.659 HD22 ' HB2' ' C' ' 32' ' ' ALA . 3.2 mp -50.8 -34.35 27.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.357 . . . . 67.650000000000006 110.863 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 106' ' ' VAL . . . . . . . . . . . . . 39.2 t -70.42 -42.86 78.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 69.590000000000003 111.067 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.401 ' CE1' ' HA3' ' D' ' 104' ' ' GLY . 2.9 m-30 -62.39 -40.75 97.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.815 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 108' ' ' ALA . . . . . 0.497 ' CB ' HG23 ' B' ' 110' ' ' VAL . . . -78.89 -34.55 44.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 80.329999999999998 110.999 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 109' ' ' ALA . . . . . 0.635 ' HB2' ' HB2' ' C' ' 29' ' ' ALA . . . -54.91 -46.34 74.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 57.57 110.986 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 110' ' ' VAL . . . . . 0.572 HG23 ' CB ' ' D' ' 108' ' ' ALA . 7.0 m -63.88 -34.71 70.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.022 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 111' ' ' ALA . . . . . 0.604 ' O ' HG23 ' C' ' 115' ' ' VAL . . . -62.6 -45.63 92.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 108.86 111.035 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 112' ' ' THR . . . . . 0.58 HG23 HG22 ' B' ' 115' ' ' VAL . 0.1 OUTLIER -59.47 -48.41 81.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 131.43000000000001 110.832 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 113' ' ' TRP . . . . . 0.58 ' CZ2' HD21 ' D' ' 24' ' ' LEU . 9.1 t90 -70.28 -31.46 68.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 166.81999999999999 110.96 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 114' ' ' PHE . . . . . 0.511 ' C ' HG21 ' D' ' 112' ' ' THR . 3.9 m-30 -62.23 -31.64 72.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 155.75999999999999 110.96 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 115' ' ' VAL . . . . . 0.604 HG23 ' O ' ' C' ' 111' ' ' ALA . 48.0 t -73.69 -30.63 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 147.30000000000001 111.169 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.82 55.98 4.84 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.749 -0.738 . . . . 141.53999999999999 112.52 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.94 90.71 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 135.47999999999999 110.886 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 7.4 pm0 -98.71 -31.96 11.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 220.34 110.89 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.246 -0.883 . . . . 185.30000000000001 110.913 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 120.838 0.352 . . . . 189.15000000000001 111.055 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 24' ' ' LEU . . . . . 0.58 HD21 ' CZ2' ' C' ' 113' ' ' TRP . 6.9 tp -169.28 -45.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 159.21000000000001 110.897 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 25' ' ' HIS . . . . . 0.41 ' HA ' ' CD2' ' C' ' 114' ' ' PHE . 8.9 p80 -55.89 -31.7 63.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 164.63999999999999 110.913 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 26' ' ' TRP . . . . . 0.414 ' HA ' ' CE3' ' D' ' 26' ' ' TRP . 0.0 OUTLIER -76.88 -63.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 179.06999999999999 110.888 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tpp85 -55.4 -51.89 65.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 187.93000000000001 110.93 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.421 ' HB1' HD23 ' D' ' 105' ' ' LEU . . . -48.45 -44.12 35.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 172.16 111.117 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.629 ' HB2' ' HB2' ' D' ' 109' ' ' ALA . . . -70.83 -44.34 66.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 119.26000000000001 111.082 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.2 -39.1 97.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.764 -0.731 . . . . 135.25999999999999 112.492 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.81 -37.55 64.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.823 0.344 . . . . 154.47999999999999 111.099 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 32' ' ' ALA . . . . . 0.852 ' HB1' ' HA ' ' D' ' 102' ' ' SER . . . -48.92 -39.85 27.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 169.43000000000001 111.094 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -35.43 68.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 97.060000000000002 110.906 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.2 -47.01 95.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 191.25 111.142 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' D' ' 32' ' ' ALA . 1.0 OUTLIER -52.12 -59.49 4.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 155.22 110.994 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.702 HD12 ' HA2' ' D' ' 99' ' ' GLY . 0.1 OUTLIER -50.81 -38.59 49.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 102.09 110.99 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.641 ' N ' HD23 ' D' ' 36' ' ' LEU . 38.3 t -63.41 -46.76 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 78.590000000000003 111.115 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 38' ' ' ILE . . . . . . . . . . . . . 68.9 mt -63.98 -62.48 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 116.39 111.079 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' VAL . . . . . . . . . . . . . 60.7 t -49.11 -32.43 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 155.25 111.094 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.616 HD21 ' HA ' ' D' ' 70' ' ' VAL . 5.3 mt -58.87 -64.18 1.03 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 46.210000000000001 110.962 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 41' ' ' LEU . . . . . 0.528 HD12 ' O ' ' D' ' 37' ' ' VAL . 0.9 OUTLIER -57.04 -54.17 49.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 70.890000000000001 110.942 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.06 -62.79 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 199.31999999999999 111.097 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . -49.0 -50.86 26.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.708 -0.758 . . . . 101.55 112.566 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 5.0 m -49.13 -56.39 9.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 90.680000000000007 110.923 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 45' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -65.12 -35.65 81.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 201.44 110.923 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.51 -46.5 88.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 127.18000000000001 110.905 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.739 ' HB2' HG21 ' D' ' 91' ' ' VAL . . . -72.25 -43.3 64.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 141.66999999999999 111.121 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 48' ' ' VAL . . . . . 0.583 HG11 ' CE1' ' D' ' 62' ' ' TYR . 2.5 t -48.04 -57.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 85.530000000000001 111.21 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.14 -31.16 5.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 191.44999999999999 111.01 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.43 -67.87 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 100.04000000000001 111.115 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -48.29 -31.42 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 90.349999999999994 110.915 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.79 -46.33 41.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 192.13999999999999 110.913 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 53' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' D' ' 54' ' ' ALA . . . -113.47 66.57 0.26 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.756 -0.735 . . . . 185.63 112.537 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 54' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' D' ' 53' ' ' GLY . . . 172.58 152.51 0.23 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.379 . . . . 117.78 111.11 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.87 90.19 0.03 OUTLIER 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.723 2.282 . . . . 56.289999999999999 112.294 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.41 -170.87 12.52 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.768 -0.73 . . . . 58.289999999999999 112.543 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 57' ' ' ALA . . . . . 0.889 ' HB2' ' O ' ' D' ' 82' ' ' TYR . . . -60.62 179.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.859 0.361 . . . . 112.43000000000001 111.097 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 58' ' ' ALA . . . . . 0.563 ' HB3' ' CD2' ' D' ' 81' ' ' LEU . . . -91.27 74.47 6.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 59' ' ' LEU . . . . . 0.724 HD11 ' HB3' ' D' ' 57' ' ' ALA . 0.0 OUTLIER -130.63 -63.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 81.400000000000006 110.797 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 38.2 pt 42.84 32.19 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.934 -0.576 . . . . 109.20999999999999 111.655 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 61' ' ' SER . . . . . . . . . . . . . 2.1 p -177.0 161.16 1.88 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.928 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 62' ' ' TYR . . . . . 0.583 ' CE1' HG11 ' D' ' 48' ' ' VAL . 3.5 m-85 -71.73 -47.79 12.02 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 197.03999999999999 111.757 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 63' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' D' ' 62' ' ' TYR . 86.1 Cg_exo -45.67 -29.06 5.01 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.156 1.904 . . . . 133.46000000000001 112.452 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.64 -45.78 5.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.94 79.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 78.299999999999997 111.1 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 66' ' ' LEU . . . . . . . . . . . . . 20.4 mt -48.44 -42.33 31.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 80.459999999999994 110.844 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 67' ' ' TRP . . . . . 0.435 ' CH2' ' HG2' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -64.32 -36.8 85.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 86.840000000000003 110.821 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -40.52 89.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 55.240000000000002 110.865 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 69' ' ' SER . . . . . 0.403 ' HB3' HG21 ' D' ' 95' ' ' VAL . 16.0 m -62.67 -42.91 99.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 76.150000000000006 110.83 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.616 ' HA ' HD21 ' D' ' 40' ' ' LEU . 40.4 t -55.64 -50.76 65.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 26.75 111.12 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.44 ' OE1' HG11 ' D' ' 76' ' ' VAL . 62.7 mm-40 -62.93 -46.98 85.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 95.299999999999997 110.819 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 72' ' ' THR . . . . . 0.424 HG22 ' HG3' ' D' ' 96' ' ' MET . 8.7 m -59.2 -32.34 69.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 104.91 110.87 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.41 -30.41 64.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 62.990000000000002 111.141 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 74' ' ' THR . . . . . 0.546 HG22 HD11 ' A' ' 100' ' ' ILE . 1.3 m -97.91 29.21 3.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 66.370000000000005 111.047 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 75' ' ' THR . . . . . . . . . . . . . 50.3 p 47.99 32.49 2.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.385 -0.37 . . . . 71.109999999999999 111.012 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 76' ' ' VAL . . . . . 0.44 HG11 ' OE1' ' D' ' 71' ' ' GLU . 24.4 t -89.68 -72.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 163.09999999999999 111.184 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 77' ' ' GLY . . . . . 0.439 ' N ' HG12 ' D' ' 76' ' ' VAL . . . 56.0 69.91 1.13 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.728 -0.749 . . . . 139.34999999999999 112.447 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 78' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -48.64 -57.99 5.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 47.600000000000001 110.947 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 79' ' ' GLY . . . . . . . . . . . . . . . 127.21 -27.48 4.78 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.733 -0.746 . . . . 77.900000000000006 112.594 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 80' ' ' ASP . . . . . 0.772 ' O ' HD23 ' D' ' 81' ' ' LEU . 7.9 p-10 -48.06 -31.95 6.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 106.89 110.971 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 81' ' ' LEU . . . . . 0.772 HD23 ' O ' ' D' ' 80' ' ' ASP . 3.5 mt -146.41 102.63 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 73.319999999999993 110.88 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 82' ' ' TYR . . . . . 0.889 ' O ' ' HB2' ' D' ' 57' ' ' ALA . 30.0 p90 -114.82 150.16 43.61 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 106.70999999999999 110.847 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 83' ' ' PRO . . . . . 0.582 ' HG3' ' HB2' ' D' ' 92' ' ' ALA . 61.3 Cg_endo -73.52 148.29 42.29 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.624 2.216 . . . . 75.739999999999995 112.35 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 45.2 t -127.12 -62.56 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 68.219999999999999 111.089 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 85' ' ' THR . . . . . 0.471 HG22 ' N ' ' D' ' 86' ' ' LEU . 57.4 m -52.12 160.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 109.83 110.833 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.471 ' N ' HG22 ' D' ' 85' ' ' THR . 0.2 OUTLIER -52.48 -58.23 7.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 179.58000000000001 110.91 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 87' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.18 -58.03 8.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 198.50999999999999 110.818 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.423 ' HA2' ' HB1' ' D' ' 47' ' ' ALA . . . -50.06 -44.77 42.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 70.909999999999997 112.419 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 89' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -69.06 -40.41 78.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 100.38 110.827 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 90' ' ' CYS . . . . . 0.712 ' O ' HG23 ' D' ' 94' ' ' VAL . 0.1 OUTLIER -55.24 -40.27 70.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 116.70999999999999 110.822 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 91' ' ' VAL . . . . . 0.739 HG21 ' HB2' ' D' ' 47' ' ' ALA . 18.8 t -62.16 -42.5 95.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 62.479999999999997 111.049 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 92' ' ' ALA . . . . . 0.582 ' HB2' ' HG3' ' D' ' 83' ' ' PRO . . . -53.86 -48.62 69.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.409999999999997 111.031 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 93' ' ' VAL . . . . . 0.427 HG22 HG11 ' C' ' 70' ' ' VAL . 23.3 t -66.49 -41.93 89.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 68.230000000000004 111.035 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.712 HG23 ' O ' ' D' ' 90' ' ' CYS . 65.8 t -63.32 -42.18 95.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 37.840000000000003 111.086 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 95' ' ' VAL . . . . . 0.403 HG21 ' HB3' ' D' ' 69' ' ' SER . 0.3 OUTLIER -73.58 -31.4 32.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 85.540000000000006 111.047 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 96' ' ' MET . . . . . 0.424 ' HG3' HG22 ' D' ' 72' ' ' THR . 0.1 OUTLIER -63.63 -51.57 64.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 86.290000000000006 110.848 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.85 -38.26 78.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 71.469999999999999 111.039 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.99 -46.37 68.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 59.409999999999997 111.034 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 99' ' ' GLY . . . . . 0.702 ' HA2' HD12 ' D' ' 36' ' ' LEU . . . -62.74 -42.43 99.69 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.75 . . . . 47.880000000000003 112.425 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 100' ' ' ILE . . . . . 0.511 HD11 HG22 ' C' ' 74' ' ' THR . 25.2 mt -68.65 -43.73 83.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.337 . . . . 114.22 111.098 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 101' ' ' THR . . . . . 0.444 ' O ' HD12 ' D' ' 105' ' ' LEU . 64.0 m -57.0 -48.3 78.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 68.569999999999993 110.843 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 102' ' ' SER . . . . . 0.852 ' HA ' ' HB1' ' D' ' 32' ' ' ALA . 15.9 m -63.58 -40.92 98.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 127.73999999999999 110.787 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 103' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -70.65 -36.91 73.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.831 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 104' ' ' GLY . . . . . 0.401 ' HA3' ' CE1' ' C' ' 107' ' ' PHE . . . -59.73 -51.11 60.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.747 -0.739 . . . . 94.569999999999993 112.45 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 105' ' ' LEU . . . . . 0.645 HD22 ' HB2' ' D' ' 32' ' ' ALA . 3.2 mp -50.82 -34.36 27.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.841 0.353 . . . . 109.91 110.834 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 106' ' ' VAL . . . . . 0.402 HG23 ' O ' ' D' ' 102' ' ' SER . 39.0 t -70.4 -42.88 78.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 51.57 111.046 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.421 ' CE1' ' HA3' ' A' ' 104' ' ' GLY . 2.9 m-30 -62.41 -40.75 97.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.777 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 108' ' ' ALA . . . . . 0.572 ' CB ' HG23 ' C' ' 110' ' ' VAL . . . -78.83 -34.63 45.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 66.799999999999997 110.985 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 109' ' ' ALA . . . . . 0.629 ' HB2' ' HB2' ' D' ' 29' ' ' ALA . . . -54.88 -46.36 74.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 66.859999999999999 111.002 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 m -63.84 -34.78 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.001 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 111' ' ' ALA . . . . . 0.593 ' O ' HG23 ' D' ' 115' ' ' VAL . . . -62.52 -45.73 91.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.462 . . . . 122.81 110.998 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 112' ' ' THR . . . . . 0.511 HG21 ' C ' ' C' ' 114' ' ' PHE . 0.1 OUTLIER -59.44 -48.39 81.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 128.65000000000001 110.834 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 113' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -70.27 -31.52 68.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 187.44 110.928 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 114' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -62.25 -31.61 72.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 140.41 110.917 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 115' ' ' VAL . . . . . 0.593 HG23 ' O ' ' D' ' 111' ' ' ALA . 48.1 t -73.75 -30.78 29.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 154.47 111.174 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.43 57.06 4.94 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.714 -0.755 . . . . 147.03 112.512 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 117' ' ' ARG . . . . . 0.851 ' HD2' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -165.87 62.06 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.828 0.347 . . . . 129.09 110.886 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -31.72 73.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 219.72 110.923 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 119' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.246 -0.883 . . . . 171.94 110.904 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 801' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.819 0.342 . . . . 20.0 111.583 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 802' ' ' PHE . . . . . 0.417 ' CE1' ' HD3' ' E' ' 834' ' ' ARG . 9.5 m-85 -122.75 104.3 9.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 20.0 110.831 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 803' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.03 -178.72 3.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 20.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 804' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -80.53 75.24 7.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 20.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 805' ' ' VAL . . . . . 0.594 HG13 HG11 ' E' ' 816' ' ' VAL . 93.7 t -109.11 129.62 63.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 20.0 111.17 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 806' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.66 159.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 20.0 110.87 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 807' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.73 110.01 11.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 20.0 110.899 -179.949 -117.673 -46.451 -135.565 103.796 2.029 103.79 -50.676 -132.955 2 2 . 1 . 001 nuclear build full ' E' E ' 808' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.11 -48.59 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 20.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 809' ' ' THR . . . . . . . . . . . . . 2.4 m -143.0 164.32 30.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 20.0 110.86 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 810' ' ' SER . . . . . . . . . . . . . 25.6 p -85.63 -38.75 18.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 20.0 110.909 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 811' ' ' LYS . . . . . 0.428 ' HA ' ' CZ3' ' E' ' 814' ' ' TRP . 17.5 mttp -56.51 -34.52 67.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 20.0 110.955 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 812' ' ' GLU . . . . . 0.452 ' O ' HG23 ' E' ' 816' ' ' VAL . 0.5 OUTLIER -86.04 -32.41 21.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 20.0 110.952 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 813' ' ' CYS . . . . . . . . . . . . . 1.1 m -52.5 -31.69 36.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 20.0 110.876 -179.994 -99.572 -97.088 152.062 103.789 2.03 103.786 137.128 -177.327 1 1 . 1 . 001 nuclear build full ' E' E ' 814' ' ' TRP . . . . . 0.428 ' CZ3' ' HA ' ' E' ' 811' ' ' LYS . 1.8 m0 -73.5 -53.0 11.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 20.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 815' ' ' SER . . . . . . . . . . . . . 4.4 m -50.41 -33.7 21.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 20.0 110.917 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 816' ' ' VAL . . . . . 0.594 HG11 HG13 ' E' ' 805' ' ' VAL . 57.9 t -71.49 -42.05 72.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 20.0 111.087 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 817' ' ' CYS . . . . . . . . . . . . . 86.5 m -61.73 -48.21 81.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 20.0 110.884 179.996 -67.803 -55.612 -102.458 103.851 2.029 103.831 -60.518 -78.195 1 1 . 1 . 001 nuclear build full ' E' E ' 818' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -62.13 -36.65 82.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 20.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 819' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -45.42 56.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 20.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 820' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.85 -66.8 0.39 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 20.0 110.942 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 821' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.09 -76.9 0.57 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 20.0 110.918 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 822' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 171.45 48.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 20.0 110.882 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 823' ' ' THR . . . . . . . . . . . . . 51.2 p -136.25 173.3 11.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 20.0 110.909 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 824' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.55 -178.2 6.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 20.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 825' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? 57.97 104.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 20.0 110.907 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 826' ' ' GLY . . . . . . . . . . . . . . . -164.52 128.42 1.8 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.742 -0.742 . . . . 20.0 112.512 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 827' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.73 166.61 6.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.848 0.356 . . . . 20.0 110.857 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 828' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.43 129.6 55.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 20.0 110.876 -179.999 -132.955 -50.676 -135.565 103.79 2.029 103.796 -46.451 -117.673 2 2 . 1 . 001 nuclear build full ' E' E ' 829' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.8 147.74 29.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 20.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 830' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -48.68 -31.63 7.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 20.0 110.917 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 831' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.32 -69.35 0.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 20.0 110.9 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 832' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.94 146.47 25.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 20.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 833' ' ' CYS . . . . . . . . . . . . . 47.5 t -59.8 130.21 45.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 20.0 110.869 -179.981 -177.327 137.128 152.062 103.786 2.03 103.789 -97.088 -99.572 1 1 . 1 . 001 nuclear build full ' E' E ' 834' ' ' ARG . . . . . 0.417 ' HD3' ' CE1' ' E' ' 802' ' ' PHE . 91.1 mtt180 -99.12 136.56 38.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 20.0 110.941 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 835' ' ' CYS . . . . . . . . . . . . . 33.9 m -92.1 144.52 25.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 20.0 110.816 -179.971 -78.195 -60.518 -102.458 103.831 2.029 103.851 -55.612 -67.803 1 1 . 1 . 001 nuclear build full ' E' E ' 836' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.01 178.23 7.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 20.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 837' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.201 -0.904 . . . . 20.0 110.862 -179.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.817 0.341 . . . . 181.62 111.047 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.851 HD22 ' HD2' ' D' ' 117' ' ' ARG . 6.9 tp -177.23 -44.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 163.39 110.955 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -55.92 -31.73 63.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 154.92 110.93 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.406 ' CE3' ' HA ' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -76.84 -63.93 1.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 178.34 110.882 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tpp85 -55.43 -51.91 65.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 182.99 110.9 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.418 ' HB1' HD23 ' A' ' 105' ' ' LEU . . . -48.37 -44.21 34.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 172.56 111.109 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.634 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . . . -70.79 -44.34 66.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 108.12 111.12 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.16 -39.13 97.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.691 -0.766 . . . . 114.36 112.528 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.74 -37.59 65.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.822 0.344 . . . . 156.87 111.106 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.873 ' HB1' ' HA ' ' A' ' 102' ' ' SER . . . -48.86 -39.89 27.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 168.03 111.091 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.75 -35.41 68.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 124.14 110.876 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.24 -46.92 95.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 186.53 111.144 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -52.17 -59.52 4.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 143.06 110.958 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.715 HD12 ' HA2' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -50.72 -38.62 48.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 121.26 110.979 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.628 ' N ' HD23 ' A' ' 36' ' ' LEU . 38.1 t -63.47 -46.72 94.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 66.03 111.084 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.1 mt -63.96 -62.55 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 116.76 111.05 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -49.15 -32.35 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 140.44 111.099 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 70' ' ' VAL . 5.4 mt -58.9 -64.18 1.03 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 56.44 110.921 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.532 HD12 ' O ' ' A' ' 37' ' ' VAL . 0.9 OUTLIER -57.17 -54.05 51.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 60.81 110.937 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.04 -62.79 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 201.16 111.099 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -49.05 -50.84 26.79 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.666 -0.778 . . . . 121.73 112.549 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.0 m -49.14 -56.37 9.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 75.75 110.956 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -65.11 -35.61 81.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 207.41 110.934 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.61 -46.44 88.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 119.83 110.864 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.759 ' HB2' HG21 ' A' ' 91' ' ' VAL . . . -72.28 -43.29 64.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 146.28 111.125 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.675 HG11 ' CE1' ' A' ' 62' ' ' TYR . 2.5 t -48.02 -58.01 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 103.3 111.183 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.17 -31.14 5.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 186.57 111.002 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.38 -67.9 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 91.45 111.149 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -48.24 -31.44 5.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 140.74 110.919 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.431 ' HA ' HG22 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -48.66 -46.26 39.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 184.01 110.925 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.0 49.84 0.82 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.702 -0.761 . . . . 183.51 112.506 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.619 ' HB1' ' HD2' ' A' ' 55' ' ' PRO . . . -157.9 161.99 27.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 129.6 111.141 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.619 ' HD2' ' HB1' ' A' ' 54' ' ' ALA . 53.6 Cg_endo -69.74 87.31 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.752 2.301 . . . . 74.93 112.314 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -125.12 -172.9 13.56 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.739 -0.743 . . . . 60.75 112.5 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.96 -70.53 0.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 121.54 111.088 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -163.89 31.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.137 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.755 HD22 ' CE3' ' A' ' 68' ' ' TRP . 29.7 mt -92.98 50.88 1.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 89.3 110.863 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 48' ' ' VAL . 19.4 pt -96.58 -32.21 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 97.34 111.145 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.09 156.25 24.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.85 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.675 ' CE1' HG11 ' A' ' 48' ' ' VAL . 4.9 m-85 -69.78 -47.54 23.86 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 185.28 111.57 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 62' ' ' TYR . 87.6 Cg_exo -46.51 -28.92 6.71 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.102 1.868 . . . . 106.64 112.266 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.41 -45.84 5.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.8 -48.91 79.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 93.68 111.115 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.3 mt -48.4 -42.37 31.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 73.79 110.876 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -36.75 85.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 92.48 110.836 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.755 ' CE3' HD22 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -66.54 -40.55 89.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 65.1 110.856 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.9 m -62.63 -42.89 99.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 60.16 110.868 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.634 ' HA ' HD21 ' A' ' 40' ' ' LEU . 40.3 t -55.71 -50.71 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 40.96 111.033 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.451 ' OE1' HG11 ' A' ' 76' ' ' VAL . 62.7 mm-40 -63.0 -46.89 85.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 91.8 110.837 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.446 HG22 ' HG3' ' A' ' 96' ' ' MET . 9.1 m -59.25 -32.28 69.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 93.49 110.853 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.36 -30.51 64.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 78.09 111.144 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.489 HG22 HD11 ' B' ' 100' ' ' ILE . 1.5 m -98.17 29.64 3.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 80.41 111.067 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 50.1 p 47.94 32.59 2.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.347 -0.388 . . . . 78.57 110.994 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.451 HG11 ' OE1' ' A' ' 71' ' ' GLU . 25.6 t -90.54 -74.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 146.85 111.108 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.443 ' N ' HG12 ' A' ' 76' ' ' VAL . . . 56.53 69.89 1.14 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.698 -0.763 . . . . 148.34 112.485 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -48.54 -56.84 7.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 62.83 110.929 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.45 -31.96 2.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.742 -0.742 . . . . 72.42 112.502 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -50.54 -52.47 38.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.836 0.35 . . . . 83.32 110.894 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.77 101.45 9.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 85.94 110.882 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -125.21 150.8 68.2 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 98.82 110.912 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.435 ' HG2' ' CH2' ' D' ' 67' ' ' TRP . 66.5 Cg_endo -74.51 159.67 42.65 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.648 2.232 . . . . 90.41 112.341 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.6 t -139.31 -48.28 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 83.59 111.035 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 86' ' ' LEU . 99.3 m -74.41 160.11 31.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 97.15 110.797 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.479 ' N ' HG22 ' A' ' 85' ' ' THR . 0.2 OUTLIER -48.48 -58.25 4.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.418 . . . . 182.23 110.878 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.14 -58.02 8.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 203.73 110.863 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.417 ' HA2' ' HB1' ' A' ' 47' ' ' ALA . . . -50.07 -44.74 42.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.69 -0.767 . . . . 60.44 112.382 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -69.17 -40.32 78.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 90.5 110.78 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.716 ' O ' HG23 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -55.29 -40.25 70.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 123.86 110.818 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.759 HG21 ' HB2' ' A' ' 47' ' ' ALA . 18.7 t -62.16 -42.48 95.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 56.74 111.081 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.84 -48.69 69.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 74.35 111.049 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.0 t -66.39 -41.97 89.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.487 . . . . 85.02 111.099 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 90' ' ' CYS . 65.8 t -63.34 -42.14 95.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 50.56 111.089 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.57 -31.37 32.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 74.97 111.13 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.446 ' HG3' HG22 ' A' ' 72' ' ' THR . 0.1 OUTLIER -63.75 -51.45 64.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 87.14 110.858 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.87 -38.35 78.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 79.79 110.976 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.98 -46.36 68.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 43.54 111.004 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.715 ' HA2' HD12 ' A' ' 36' ' ' LEU . . . -62.72 -42.47 99.68 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.742 -0.742 . . . . 51.0 112.441 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.546 HD11 HG22 ' D' ' 74' ' ' THR . 25.3 mt -68.62 -43.8 83.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.348 . . . . 93.59 111.07 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.447 ' O ' HD12 ' A' ' 105' ' ' LEU . 63.8 m -56.97 -48.31 78.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 73.96 110.853 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.873 ' HA ' ' HB1' ' A' ' 32' ' ' ALA . 15.8 m -63.57 -40.9 98.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 133.82 110.862 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.62 -36.89 73.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' D' ' 107' ' ' PHE . . . -59.74 -51.15 60.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 93.93 112.43 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.654 HD22 ' HB2' ' A' ' 32' ' ' ALA . 3.2 mp -50.8 -34.38 27.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.341 . . . . 93.93 110.819 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 102' ' ' SER . 39.1 t -70.4 -42.86 78.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 46.85 111.014 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.408 ' CE1' ' HA3' ' B' ' 104' ' ' GLY . 2.9 m-30 -62.38 -40.8 97.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.782 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -78.8 -34.64 45.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 84.84 110.991 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.634 ' HB2' ' HB2' ' A' ' 29' ' ' ALA . . . -54.93 -46.32 74.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 66.9 111.011 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.514 HG23 ' CB ' ' B' ' 108' ' ' ALA . 7.0 m -63.89 -34.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.056 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.603 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -62.56 -45.61 92.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 102.69 111.054 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.419 HG23 HG22 ' D' ' 115' ' ' VAL . 0.1 OUTLIER -59.54 -48.34 82.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 140.03 110.854 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.438 ' CZ2' HD21 ' B' ' 24' ' ' LEU . 9.0 t90 -70.3 -31.5 68.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.472 . . . . 183.49 110.869 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' B' ' 25' ' ' HIS . 3.8 m-30 -62.34 -31.5 72.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 127.13 110.909 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 111' ' ' ALA . 48.1 t -73.79 -30.65 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 156.63 111.177 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -93.1 66.07 1.87 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.713 -0.756 . . . . 125.69 112.54 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.615 ' HG3' HD22 ' B' ' 24' ' ' LEU . 0.1 OUTLIER -165.99 37.27 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 119.24 110.911 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -48.47 -46.13 37.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 217.48 110.87 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.206 -0.902 . . . . 193.75 110.867 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.785 0.326 . . . . 173.57 111.057 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.615 HD22 ' HG3' ' A' ' 117' ' ' ARG . 7.0 tp -177.52 -44.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 159.27 110.873 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . 0.415 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 8.9 p80 -55.96 -31.68 63.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 154.23 110.933 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' TRP . . . . . 0.418 ' CE3' ' HA ' ' B' ' 26' ' ' TRP . 0.0 OUTLIER -76.9 -63.86 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 172.63 110.884 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tpp85 -55.46 -51.87 65.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 181.55 110.883 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.415 ' HB1' HD23 ' B' ' 105' ' ' LEU . . . -48.46 -44.16 35.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 169.17 111.071 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' B' ' 109' ' ' ALA . . . -70.83 -44.32 66.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 107.23 111.078 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.14 -39.14 97.25 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.774 -0.727 . . . . 121.85 112.523 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.83 -37.51 64.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.331 . . . . 151.29 111.081 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . 0.883 ' HB1' ' HA ' ' B' ' 102' ' ' SER . . . -48.96 -39.88 28.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 166.05 111.088 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.69 -35.41 68.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 109.18 110.965 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.29 -46.9 95.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 173.88 111.124 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' B' ' 32' ' ' ALA . 1.0 OUTLIER -52.15 -59.53 4.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 170.52 110.963 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.704 HD12 ' HA2' ' B' ' 99' ' ' GLY . 0.1 OUTLIER -50.77 -38.59 48.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 103.32 110.979 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.633 ' N ' HD23 ' B' ' 36' ' ' LEU . 38.2 t -63.43 -46.74 94.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 85.21 111.12 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.05 -62.49 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 109.28 111.047 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -49.06 -32.48 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 150.91 111.131 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' B' ' 70' ' ' VAL . 5.4 mt -58.83 -64.24 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 64.79 110.92 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.529 HD12 ' O ' ' B' ' 37' ' ' VAL . 0.9 OUTLIER -57.05 -54.14 50.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 61.75 110.916 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.04 -62.78 1.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 195.79 111.111 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -49.01 -50.88 26.49 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 121.01 112.543 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.9 m -49.15 -56.48 9.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.339 . . . . 82.01 110.888 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -65.0 -35.65 81.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 194.3 110.991 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.51 -46.49 88.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 112.87 110.945 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.757 ' HB2' HG21 ' B' ' 91' ' ' VAL . . . -72.2 -43.38 64.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 146.37 111.115 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.646 HG11 ' CE1' ' B' ' 62' ' ' TYR . 2.5 t -47.96 -58.02 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 68.98 111.177 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.13 -31.22 5.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 177.37 110.978 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.38 -67.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 95.57 111.139 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -48.29 -31.36 5.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 135.88 110.957 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.654 ' HA ' HG22 ' B' ' 60' ' ' ILE . 0.2 OUTLIER -48.73 -46.2 40.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 170.44 110.92 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.31 45.41 1.31 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 182.79 112.451 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.72 86.31 7.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 100.03 111.088 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.84 103.46 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.701 2.267 . . . . 91.33 112.322 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.35 -45.77 0.16 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 41.72 112.464 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -115.52 158.0 23.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 124.25 111.098 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.603 ' HB3' HD23 ' B' ' 81' ' ' LEU . . . -95.74 50.86 1.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.089 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.693 HD21 ' HB3' ' B' ' 81' ' ' LEU . 1.9 mt -122.77 60.25 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 71.35 110.933 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.654 HG22 ' HA ' ' B' ' 52' ' ' ARG . 4.0 pt -100.65 -31.07 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 102.69 111.158 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m -109.21 146.4 34.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.646 ' CE1' HG11 ' B' ' 48' ' ' VAL . 7.7 m-85 -65.71 -47.36 66.41 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 214.8 111.528 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' B' ' 62' ' ' TYR . 88.0 Cg_exo -46.56 -29.09 7.02 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.028 1.818 . . . . 116.8 112.28 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.49 -45.85 6.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.78 -48.98 79.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 90.91 111.057 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 20.4 mt -48.39 -42.36 31.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 96.65 110.856 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -36.8 85.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 81.17 110.868 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' TRP . . . . . 0.576 ' CE3' HD22 ' B' ' 59' ' ' LEU . 0.0 OUTLIER -66.56 -40.52 89.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 58.82 110.833 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.408 ' HB3' HG21 ' B' ' 95' ' ' VAL . 15.9 m -62.61 -42.92 99.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 68.84 110.835 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.625 ' HA ' HD21 ' B' ' 40' ' ' LEU . 40.3 t -55.73 -50.74 65.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 33.4 111.039 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.439 ' OE1' HG11 ' B' ' 76' ' ' VAL . 62.7 mm-40 -62.91 -46.97 85.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 91.8 110.847 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . 0.442 HG22 ' HG3' ' B' ' 96' ' ' MET . 8.7 m -59.19 -32.35 69.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 90.47 110.873 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.36 -30.47 64.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 58.83 111.136 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.464 HG22 HD11 ' C' ' 100' ' ' ILE . 1.4 m -98.22 29.82 3.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 49.69 111.042 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 51.0 p 47.82 32.62 2.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.329 -0.396 . . . . 73.54 111.018 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.448 HG12 ' N ' ' B' ' 77' ' ' GLY . 25.5 t -90.06 -74.73 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 146.59 111.172 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . 0.448 ' N ' HG12 ' B' ' 76' ' ' VAL . . . 56.85 70.26 1.03 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.713 -0.756 . . . . 130.62 112.531 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -48.77 -62.11 1.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.323 . . . . 53.28 110.915 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.63 -28.56 1.9 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.735 -0.745 . . . . 41.45 112.51 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -48.52 -46.2 38.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.339 . . . . 58.15 110.878 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.693 ' HB3' HD21 ' B' ' 59' ' ' LEU . 66.5 mt -111.68 106.67 15.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 60.81 110.944 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -119.87 88.59 40.45 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 101.73 110.908 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.76 132.7 10.41 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.609 2.206 . . . . 65.61 112.228 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 87.5 t -114.53 -52.14 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 94.21 111.362 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' THR . . . . . . . . . . . . . 22.7 m -54.13 153.15 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.434 -0.348 . . . . 106.2 110.904 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.61 -58.07 5.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 194.89 110.891 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.13 -58.0 9.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 178.09 110.836 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.407 ' HA2' ' HB1' ' B' ' 47' ' ' ALA . . . -50.09 -44.73 42.55 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.691 -0.766 . . . . 49.94 112.42 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -69.14 -40.37 78.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 92.12 110.783 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' CYS . . . . . 0.72 ' O ' HG23 ' B' ' 94' ' ' VAL . 0.1 OUTLIER -55.23 -40.28 70.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 115.53 110.833 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' VAL . . . . . 0.757 HG21 ' HB2' ' B' ' 47' ' ' ALA . 18.9 t -62.12 -42.53 95.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 33.46 111.064 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.89 -48.6 69.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 77.48 111.031 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 23.3 t -66.53 -41.9 89.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 83.08 111.033 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.72 HG23 ' O ' ' B' ' 90' ' ' CYS . 65.9 t -63.33 -42.22 95.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 45.5 111.027 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . 0.408 HG21 ' HB3' ' B' ' 69' ' ' SER . 0.3 OUTLIER -73.55 -31.37 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 65.46 111.076 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' MET . . . . . 0.442 ' HG3' HG22 ' B' ' 72' ' ' THR . 0.1 OUTLIER -63.76 -51.51 64.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 69.6 110.812 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -60.82 -38.34 78.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 83.36 111.022 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.97 -46.3 68.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 38.06 111.087 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . 0.704 ' HA2' HD12 ' B' ' 36' ' ' LEU . . . -62.71 -42.49 99.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.765 -0.731 . . . . 42.71 112.479 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 74' ' ' THR . 25.1 mt -68.63 -43.76 83.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.798 0.332 . . . . 101.8 111.081 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' THR . . . . . 0.449 ' O ' HD12 ' B' ' 105' ' ' LEU . 63.6 m -56.97 -48.38 78.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 40.71 110.834 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' SER . . . . . 0.883 ' HA ' ' HB1' ' B' ' 32' ' ' ALA . 15.9 m -63.54 -40.89 98.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 129.14 110.815 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -70.64 -36.94 73.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . 0.408 ' HA3' ' CE1' ' A' ' 107' ' ' PHE . . . -59.73 -51.09 61.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 89.2 112.486 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.661 HD22 ' HB2' ' B' ' 32' ' ' ALA . 3.2 mp -50.85 -34.34 27.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.347 . . . . 76.56 110.882 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . 0.408 HG23 ' O ' ' B' ' 102' ' ' SER . 39.1 t -70.43 -42.88 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 51.36 110.989 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.404 ' CE1' ' HA3' ' C' ' 104' ' ' GLY . 2.9 m-30 -62.39 -40.76 97.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.819 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . 0.514 ' CB ' HG23 ' A' ' 110' ' ' VAL . . . -78.83 -34.59 45.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 76.84 111.016 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' B' ' 29' ' ' ALA . . . -54.92 -46.34 74.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 64.82 110.989 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' VAL . . . . . 0.497 HG23 ' CB ' ' C' ' 108' ' ' ALA . 7.0 m -63.91 -34.66 69.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.032 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.591 ' O ' HG23 ' B' ' 115' ' ' VAL . . . -62.56 -45.71 91.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 102.37 110.948 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.488 HG23 HG22 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -59.5 -48.36 81.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 129.01 110.834 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -70.26 -31.52 68.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 165.57 110.916 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' PHE . . . . . 0.42 ' CD2' ' HA ' ' C' ' 25' ' ' HIS . 3.9 m-30 -62.29 -31.5 72.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 135.15 110.926 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.591 HG23 ' O ' ' B' ' 111' ' ' ALA . 48.2 t -73.79 -30.63 29.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 146.34 111.139 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -88.4 52.44 4.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.743 . . . . 138.06 112.583 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . 0.495 ' HG3' HD22 ' C' ' 24' ' ' LEU . 0.0 OUTLIER -163.25 31.05 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.882 0.372 . . . . 115.28 110.96 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.56 -32.79 8.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 227.64 110.862 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.257 -0.877 . . . . 167.9 110.924 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.865 0.364 . . . . 185.72 111.049 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.495 HD22 ' HG3' ' B' ' 117' ' ' ARG . 6.9 tp -161.23 -45.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 139.11 110.878 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' HIS . . . . . 0.42 ' HA ' ' CD2' ' B' ' 114' ' ' PHE . 8.9 p80 -55.9 -31.75 63.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 139.32 110.895 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' TRP . . . . . 0.4 ' CE3' ' HA ' ' C' ' 26' ' ' TRP . 0.0 OUTLIER -76.79 -63.9 1.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 190.57 110.923 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tpp85 -55.38 -51.93 65.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 184.77 110.911 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.418 ' HB1' HD23 ' C' ' 105' ' ' LEU . . . -48.38 -44.19 34.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 172.75 111.122 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.635 ' HB2' ' HB2' ' C' ' 109' ' ' ALA . . . -70.79 -44.33 66.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 113.77 111.118 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.19 -39.14 97.28 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 117.7 112.455 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.77 -37.62 64.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.351 . . . . 157.58 111.047 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.878 ' HB1' ' HA ' ' C' ' 102' ' ' SER . . . -48.85 -39.89 27.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 170.66 111.128 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.74 -35.4 68.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 93.46 110.879 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.3 -46.88 95.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 178.14 111.153 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' C' ' 32' ' ' ALA . 1.0 OUTLIER -52.15 -59.6 4.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 157.86 110.899 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.719 HD12 ' HA2' ' C' ' 99' ' ' GLY . 0.1 OUTLIER -50.71 -38.59 48.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 112.92 111.017 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.636 ' N ' HD23 ' C' ' 36' ' ' LEU . 38.2 t -63.4 -46.78 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 80.26 111.131 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.96 -62.53 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 121.53 111.096 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 60.7 t -49.02 -32.49 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 139.06 111.091 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.626 HD21 ' HA ' ' C' ' 70' ' ' VAL . 5.4 mt -58.83 -64.26 1.0 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 48.09 110.916 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' LEU . . . . . 0.527 HD12 ' O ' ' C' ' 37' ' ' VAL . 0.9 OUTLIER -57.1 -54.08 50.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 67.05 110.897 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.1 -62.73 1.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 191.27 111.097 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -49.03 -50.88 26.6 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 127.02 112.541 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 5.0 m -49.14 -56.43 9.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.848 0.356 . . . . 63.12 110.902 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -65.04 -35.66 81.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 202.2 110.988 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.54 -46.47 88.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 106.63 110.94 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.746 ' HB2' HG21 ' C' ' 91' ' ' VAL . . . -72.24 -43.33 64.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 143.48 111.128 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . 0.5 HG11 ' CE1' ' C' ' 62' ' ' TYR . 2.6 t -47.95 -58.02 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 83.71 111.191 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.21 -31.16 5.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 182.32 110.995 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.34 -67.9 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 101.6 111.152 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . 0.58 ' HG3' HD11 ' C' ' 59' ' ' LEU . 11.7 mm-40 -48.32 -31.36 5.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 126.82 110.933 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.66 ' HA ' HG22 ' C' ' 60' ' ' ILE . 0.2 OUTLIER -48.82 -46.27 41.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 168.73 110.931 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' C' ' 54' ' ' ALA . . . -123.0 86.27 0.38 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.715 -0.755 . . . . 179.08 112.557 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' C' ' 53' ' ' GLY . . . 172.12 150.69 0.21 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.814 0.34 . . . . 143.79 111.075 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.41 60.86 5.04 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.69 2.26 . . . . 70.99 112.334 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.1 -79.66 1.14 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.76 -0.733 . . . . 45.12 112.514 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' C' ' 82' ' ' TYR . . . -134.29 -166.33 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.814 0.34 . . . . 121.38 111.094 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.99 -34.24 18.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.071 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.58 HD11 ' HG3' ' C' ' 51' ' ' GLU . 0.5 OUTLIER -49.62 111.02 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 53.5 110.878 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.66 HG22 ' HA ' ' C' ' 52' ' ' ARG . 3.0 pt -139.01 30.78 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 97.34 111.158 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' SER . . . . . . . . . . . . . 2.1 m -160.76 167.06 27.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.77 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' TYR . . . . . 0.5 ' CE1' HG11 ' C' ' 48' ' ' VAL . 1.4 m-85 -78.57 -48.97 1.76 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 155.48 111.396 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' C' ' 62' ' ' TYR . 77.3 Cg_exo -47.58 -28.19 8.71 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.096 1.864 . . . . 123.82 112.319 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.21 -45.7 5.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.78 -48.98 79.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 82.72 111.083 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 20.4 mt -48.37 -42.37 31.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 91.34 110.897 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' TRP . . . . . 0.43 ' CH2' ' HG2' ' D' ' 83' ' ' PRO . 0.0 OUTLIER -64.32 -36.71 85.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 77.07 110.867 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' TRP . . . . . 0.679 ' HB2' HD12 ' C' ' 81' ' ' LEU . 0.0 OUTLIER -66.54 -40.54 89.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 53.26 110.894 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' SER . . . . . 0.402 ' HB3' HG21 ' C' ' 95' ' ' VAL . 15.9 m -62.62 -42.9 99.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 83.47 110.88 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.626 ' HA ' HD21 ' C' ' 40' ' ' LEU . 40.4 t -55.65 -50.75 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 35.37 111.077 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.446 ' OE1' HG11 ' C' ' 76' ' ' VAL . 62.7 mm-40 -62.99 -46.91 85.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 91.8 110.828 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . 0.438 HG22 ' HG3' ' C' ' 96' ' ' MET . 8.7 m -59.26 -32.33 69.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 84.25 110.873 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.3 -30.56 64.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 67.97 111.14 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' THR . . . . . 0.511 HG22 HD11 ' D' ' 100' ' ' ILE . 1.5 m -97.93 29.48 3.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 23.63 111.105 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' THR . . . . . . . . . . . . . 50.4 p 47.86 32.62 2.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.364 -0.38 . . . . 65.21 111.024 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' VAL . . . . . 0.446 HG11 ' OE1' ' C' ' 71' ' ' GLU . 25.4 t -90.01 -74.4 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 149.65 111.131 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' GLY . . . . . 0.442 ' N ' HG12 ' C' ' 76' ' ' VAL . . . 56.81 69.53 1.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.724 -0.75 . . . . 161.6 112.509 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' D' ' 82' ' ' TYR . 27.1 m-85 -48.83 -58.05 5.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.833 0.349 . . . . 80.0 110.98 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' GLY . . . . . 0.404 ' O ' ' CD2' ' C' ' 82' ' ' TYR . . . 136.61 -27.4 2.96 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.661 -0.78 . . . . 74.91 112.545 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' ASP . . . . . 0.441 ' CB ' ' CZ ' ' D' ' 82' ' ' TYR . 6.1 p-10 -48.16 -31.75 6.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 67.6 110.977 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' LEU . . . . . 0.679 HD12 ' HB2' ' C' ' 68' ' ' TRP . 56.7 mt -120.49 111.28 17.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 75.99 110.855 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' TYR . . . . . 0.449 ' O ' ' HB2' ' C' ' 57' ' ' ALA . 0.1 OUTLIER -121.52 88.93 46.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 100.23 110.959 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.61 122.95 10.46 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.43 2.086 . . . . 85.79 112.18 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 t -102.57 -40.16 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 72.85 111.383 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' THR . . . . . . . . . . . . . 59.7 m -50.26 154.92 1.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 92.04 110.77 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.32 -58.4 8.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 177.2 110.89 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.08 -58.11 8.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 201.42 110.833 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . 0.416 ' HA2' ' HB1' ' C' ' 47' ' ' ALA . . . -49.96 -44.82 41.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.724 -0.75 . . . . 64.22 112.42 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -69.08 -40.42 78.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 108.14 110.824 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' CYS . . . . . 0.721 ' O ' HG23 ' C' ' 94' ' ' VAL . 0.1 OUTLIER -55.14 -40.29 70.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 107.02 110.879 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' VAL . . . . . 0.746 HG21 ' HB2' ' C' ' 47' ' ' ALA . 18.8 t -62.16 -42.49 95.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 51.75 111.096 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.92 -48.58 70.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 82.86 111.033 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.424 HG22 HG11 ' B' ' 70' ' ' VAL . 23.2 t -66.49 -41.94 89.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 54.67 111.03 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.721 HG23 ' O ' ' C' ' 90' ' ' CYS . 65.8 t -63.33 -42.19 95.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 44.26 111.046 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' C' ' 69' ' ' SER . 0.3 OUTLIER -73.6 -31.34 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 63.71 111.1 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' MET . . . . . 0.438 ' HG3' HG22 ' C' ' 72' ' ' THR . 0.1 OUTLIER -63.72 -51.54 64.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 90.8 110.857 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.8 -38.31 78.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 46.3 111.028 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.02 -46.31 68.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 52.09 111.052 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . 0.719 ' HA2' HD12 ' C' ' 36' ' ' LEU . . . -62.73 -42.47 99.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 20.59 112.423 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' ILE . . . . . 0.464 HD11 HG22 ' B' ' 74' ' ' THR . 25.3 mt -68.66 -43.73 83.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.75 0.309 . . . . 93.27 111.084 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' THR . . . . . 0.448 ' O ' HD12 ' C' ' 105' ' ' LEU . 63.4 m -57.0 -48.31 78.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 38.86 110.827 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . 0.878 ' HA ' ' HB1' ' C' ' 32' ' ' ALA . 15.9 m -63.57 -40.89 98.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 147.09 110.833 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -70.73 -36.84 73.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.835 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' B' ' 107' ' ' PHE . . . -59.77 -51.11 60.96 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.737 -0.744 . . . . 65.9 112.443 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.659 HD22 ' HB2' ' C' ' 32' ' ' ALA . 3.2 mp -50.8 -34.35 27.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.357 . . . . 67.65 110.863 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' VAL . . . . . . . . . . . . . 39.2 t -70.42 -42.86 78.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 69.59 111.067 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.401 ' CE1' ' HA3' ' D' ' 104' ' ' GLY . 2.9 m-30 -62.39 -40.75 97.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.815 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' ALA . . . . . 0.497 ' CB ' HG23 ' B' ' 110' ' ' VAL . . . -78.89 -34.55 44.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 80.33 110.999 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' ALA . . . . . 0.635 ' HB2' ' HB2' ' C' ' 29' ' ' ALA . . . -54.91 -46.34 74.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 57.57 110.986 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' VAL . . . . . 0.572 HG23 ' CB ' ' D' ' 108' ' ' ALA . 7.0 m -63.88 -34.71 70.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.022 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . 0.604 ' O ' HG23 ' C' ' 115' ' ' VAL . . . -62.6 -45.63 92.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 108.86 111.035 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' THR . . . . . 0.58 HG23 HG22 ' B' ' 115' ' ' VAL . 0.1 OUTLIER -59.47 -48.41 81.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 131.43 110.832 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' TRP . . . . . 0.58 ' CZ2' HD21 ' D' ' 24' ' ' LEU . 9.1 t90 -70.28 -31.46 68.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 166.82 110.96 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' PHE . . . . . 0.511 ' C ' HG21 ' D' ' 112' ' ' THR . 3.9 m-30 -62.23 -31.64 72.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 155.76 110.96 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' VAL . . . . . 0.604 HG23 ' O ' ' C' ' 111' ' ' ALA . 48.0 t -73.69 -30.63 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 147.3 111.169 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.82 55.98 4.84 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.749 -0.738 . . . . 141.54 112.52 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.94 90.71 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 135.48 110.886 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 7.4 pm0 -98.71 -31.96 11.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 220.34 110.89 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.246 -0.883 . . . . 185.3 110.913 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 120.838 0.352 . . . . 189.15 111.055 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' LEU . . . . . 0.58 HD21 ' CZ2' ' C' ' 113' ' ' TRP . 6.9 tp -169.28 -45.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 159.21 110.897 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' HIS . . . . . 0.41 ' HA ' ' CD2' ' C' ' 114' ' ' PHE . 8.9 p80 -55.89 -31.7 63.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 164.64 110.913 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' TRP . . . . . 0.414 ' HA ' ' CE3' ' D' ' 26' ' ' TRP . 0.0 OUTLIER -76.88 -63.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 179.07 110.888 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tpp85 -55.4 -51.89 65.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 187.93 110.93 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.421 ' HB1' HD23 ' D' ' 105' ' ' LEU . . . -48.45 -44.12 35.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 172.16 111.117 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.629 ' HB2' ' HB2' ' D' ' 109' ' ' ALA . . . -70.83 -44.34 66.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 119.26 111.082 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.2 -39.1 97.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.764 -0.731 . . . . 135.26 112.492 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.81 -37.55 64.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.823 0.344 . . . . 154.48 111.099 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' ALA . . . . . 0.852 ' HB1' ' HA ' ' D' ' 102' ' ' SER . . . -48.92 -39.85 27.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 169.43 111.094 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -35.43 68.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 97.06 110.906 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.2 -47.01 95.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 191.25 111.142 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' D' ' 32' ' ' ALA . 1.0 OUTLIER -52.12 -59.49 4.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 155.22 110.994 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.702 HD12 ' HA2' ' D' ' 99' ' ' GLY . 0.1 OUTLIER -50.81 -38.59 49.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 102.09 110.99 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.641 ' N ' HD23 ' D' ' 36' ' ' LEU . 38.3 t -63.41 -46.76 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 78.59 111.115 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' ILE . . . . . . . . . . . . . 68.9 mt -63.98 -62.48 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 116.39 111.079 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' VAL . . . . . . . . . . . . . 60.7 t -49.11 -32.43 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 155.25 111.094 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.616 HD21 ' HA ' ' D' ' 70' ' ' VAL . 5.3 mt -58.87 -64.18 1.03 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 46.21 110.962 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' LEU . . . . . 0.528 HD12 ' O ' ' D' ' 37' ' ' VAL . 0.9 OUTLIER -57.04 -54.17 49.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 70.89 110.942 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.06 -62.79 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 199.32 111.097 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . -49.0 -50.86 26.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.708 -0.758 . . . . 101.55 112.566 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 5.0 m -49.13 -56.39 9.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 90.68 110.923 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -65.12 -35.65 81.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 201.44 110.923 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.51 -46.5 88.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 127.18 110.905 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.739 ' HB2' HG21 ' D' ' 91' ' ' VAL . . . -72.25 -43.3 64.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 141.67 111.121 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' VAL . . . . . 0.583 HG11 ' CE1' ' D' ' 62' ' ' TYR . 2.5 t -48.04 -57.98 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 85.53 111.21 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.14 -31.16 5.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 191.45 111.01 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.43 -67.87 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 100.04 111.115 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -48.29 -31.42 5.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 90.35 110.915 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.79 -46.33 41.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 192.14 110.913 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' D' ' 54' ' ' ALA . . . -113.47 66.57 0.26 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.756 -0.735 . . . . 185.63 112.537 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' D' ' 53' ' ' GLY . . . 172.58 152.51 0.23 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.379 . . . . 117.78 111.11 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.87 90.19 0.03 OUTLIER 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.723 2.282 . . . . 56.29 112.294 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.41 -170.87 12.52 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.768 -0.73 . . . . 58.29 112.543 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' ALA . . . . . 0.889 ' HB2' ' O ' ' D' ' 82' ' ' TYR . . . -60.62 179.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.859 0.361 . . . . 112.43 111.097 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' ALA . . . . . 0.563 ' HB3' ' CD2' ' D' ' 81' ' ' LEU . . . -91.27 74.47 6.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . 0.724 HD11 ' HB3' ' D' ' 57' ' ' ALA . 0.0 OUTLIER -130.63 -63.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 81.4 110.797 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' ILE . . . . . . . . . . . . . 38.2 pt 42.84 32.19 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.934 -0.576 . . . . 109.21 111.655 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' SER . . . . . . . . . . . . . 2.1 p -177.0 161.16 1.88 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.928 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' TYR . . . . . 0.583 ' CE1' HG11 ' D' ' 48' ' ' VAL . 3.5 m-85 -71.73 -47.79 12.02 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 197.04 111.757 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' D' ' 62' ' ' TYR . 86.1 Cg_exo -45.67 -29.06 5.01 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.156 1.904 . . . . 133.46 112.452 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.64 -45.78 5.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.94 79.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 78.3 111.1 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' LEU . . . . . . . . . . . . . 20.4 mt -48.44 -42.33 31.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 80.46 110.844 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' TRP . . . . . 0.435 ' CH2' ' HG2' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -64.32 -36.8 85.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 86.84 110.821 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -40.52 89.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 55.24 110.865 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' SER . . . . . 0.403 ' HB3' HG21 ' D' ' 95' ' ' VAL . 16.0 m -62.67 -42.91 99.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 76.15 110.83 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.616 ' HA ' HD21 ' D' ' 40' ' ' LEU . 40.4 t -55.64 -50.76 65.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 26.75 111.12 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.44 ' OE1' HG11 ' D' ' 76' ' ' VAL . 62.7 mm-40 -62.93 -46.98 85.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 95.3 110.819 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . 0.424 HG22 ' HG3' ' D' ' 96' ' ' MET . 8.7 m -59.2 -32.34 69.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 104.91 110.87 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.41 -30.41 64.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 62.99 111.141 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' THR . . . . . 0.546 HG22 HD11 ' A' ' 100' ' ' ILE . 1.3 m -97.91 29.21 3.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 66.37 111.047 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' THR . . . . . . . . . . . . . 50.3 p 47.99 32.49 2.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.385 -0.37 . . . . 71.11 111.012 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' VAL . . . . . 0.44 HG11 ' OE1' ' D' ' 71' ' ' GLU . 24.4 t -89.68 -72.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 163.1 111.184 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' GLY . . . . . 0.439 ' N ' HG12 ' D' ' 76' ' ' VAL . . . 56.0 69.91 1.13 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.728 -0.749 . . . . 139.35 112.447 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -48.64 -57.99 5.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 47.6 110.947 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' GLY . . . . . . . . . . . . . . . 127.21 -27.48 4.78 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.733 -0.746 . . . . 77.9 112.594 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' ASP . . . . . 0.772 ' O ' HD23 ' D' ' 81' ' ' LEU . 7.9 p-10 -48.06 -31.95 6.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 106.89 110.971 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . 0.772 HD23 ' O ' ' D' ' 80' ' ' ASP . 3.5 mt -146.41 102.63 3.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 73.32 110.88 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' TYR . . . . . 0.889 ' O ' ' HB2' ' D' ' 57' ' ' ALA . 30.0 p90 -114.82 150.16 43.61 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 106.71 110.847 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' PRO . . . . . 0.582 ' HG3' ' HB2' ' D' ' 92' ' ' ALA . 61.3 Cg_endo -73.52 148.29 42.29 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.624 2.216 . . . . 75.74 112.35 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 45.2 t -127.12 -62.56 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 68.22 111.089 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' THR . . . . . 0.471 HG22 ' N ' ' D' ' 86' ' ' LEU . 57.4 m -52.12 160.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 109.83 110.833 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.471 ' N ' HG22 ' D' ' 85' ' ' THR . 0.2 OUTLIER -52.48 -58.23 7.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 179.58 110.91 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.18 -58.03 8.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 198.51 110.818 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.423 ' HA2' ' HB1' ' D' ' 47' ' ' ALA . . . -50.06 -44.77 42.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 70.91 112.419 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -69.06 -40.41 78.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 100.38 110.827 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' CYS . . . . . 0.712 ' O ' HG23 ' D' ' 94' ' ' VAL . 0.1 OUTLIER -55.24 -40.27 70.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 116.71 110.822 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' VAL . . . . . 0.739 HG21 ' HB2' ' D' ' 47' ' ' ALA . 18.8 t -62.16 -42.5 95.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 62.48 111.049 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' ALA . . . . . 0.582 ' HB2' ' HG3' ' D' ' 83' ' ' PRO . . . -53.86 -48.62 69.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.41 111.031 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' VAL . . . . . 0.427 HG22 HG11 ' C' ' 70' ' ' VAL . 23.3 t -66.49 -41.93 89.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 68.23 111.035 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.712 HG23 ' O ' ' D' ' 90' ' ' CYS . 65.8 t -63.32 -42.18 95.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 37.84 111.086 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . 0.403 HG21 ' HB3' ' D' ' 69' ' ' SER . 0.3 OUTLIER -73.58 -31.4 32.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 85.54 111.047 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 96' ' ' MET . . . . . 0.424 ' HG3' HG22 ' D' ' 72' ' ' THR . 0.1 OUTLIER -63.63 -51.57 64.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 86.29 110.848 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.85 -38.26 78.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 71.47 111.039 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.99 -46.37 68.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 59.41 111.034 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . 0.702 ' HA2' HD12 ' D' ' 36' ' ' LEU . . . -62.74 -42.43 99.69 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.75 . . . . 47.88 112.425 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 100' ' ' ILE . . . . . 0.511 HD11 HG22 ' C' ' 74' ' ' THR . 25.2 mt -68.65 -43.73 83.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.337 . . . . 114.22 111.098 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 101' ' ' THR . . . . . 0.444 ' O ' HD12 ' D' ' 105' ' ' LEU . 64.0 m -57.0 -48.3 78.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 68.57 110.843 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 102' ' ' SER . . . . . 0.852 ' HA ' ' HB1' ' D' ' 32' ' ' ALA . 15.9 m -63.58 -40.92 98.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 127.74 110.787 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 103' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -70.65 -36.91 73.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.831 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 104' ' ' GLY . . . . . 0.401 ' HA3' ' CE1' ' C' ' 107' ' ' PHE . . . -59.73 -51.11 60.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.747 -0.739 . . . . 94.57 112.45 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . 0.645 HD22 ' HB2' ' D' ' 32' ' ' ALA . 3.2 mp -50.82 -34.36 27.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.841 0.353 . . . . 109.91 110.834 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 106' ' ' VAL . . . . . 0.402 HG23 ' O ' ' D' ' 102' ' ' SER . 39.0 t -70.4 -42.88 78.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 51.57 111.046 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.421 ' CE1' ' HA3' ' A' ' 104' ' ' GLY . 2.9 m-30 -62.41 -40.75 97.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.777 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 108' ' ' ALA . . . . . 0.572 ' CB ' HG23 ' C' ' 110' ' ' VAL . . . -78.83 -34.63 45.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 66.8 110.985 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 109' ' ' ALA . . . . . 0.629 ' HB2' ' HB2' ' D' ' 29' ' ' ALA . . . -54.88 -46.36 74.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 66.86 111.002 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 m -63.84 -34.78 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.001 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 111' ' ' ALA . . . . . 0.593 ' O ' HG23 ' D' ' 115' ' ' VAL . . . -62.52 -45.73 91.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.462 . . . . 122.81 110.998 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 112' ' ' THR . . . . . 0.511 HG21 ' C ' ' C' ' 114' ' ' PHE . 0.1 OUTLIER -59.44 -48.39 81.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 128.65 110.834 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 113' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -70.27 -31.52 68.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 187.44 110.928 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 114' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -62.25 -31.61 72.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 140.41 110.917 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 115' ' ' VAL . . . . . 0.593 HG23 ' O ' ' D' ' 111' ' ' ALA . 48.1 t -73.75 -30.78 29.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 154.47 111.174 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.43 57.06 4.94 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.714 -0.755 . . . . 147.03 112.512 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 117' ' ' ARG . . . . . 0.851 ' HD2' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -165.87 62.06 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.828 0.347 . . . . 129.09 110.886 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -31.72 73.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 219.72 110.923 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 119' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.246 -0.883 . . . . 171.94 110.904 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 801' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.819 0.342 . . . . 20.0 111.583 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 802' ' ' PHE . . . . . 0.417 ' CE1' ' HD3' ' E' ' 834' ' ' ARG . 9.5 m-85 -122.75 104.3 9.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 20.0 110.831 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 803' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.03 -178.72 3.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 20.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 804' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -80.53 75.24 7.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 20.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 805' ' ' VAL . . . . . 0.594 HG13 HG11 ' E' ' 816' ' ' VAL . 93.7 t -109.11 129.62 63.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 20.0 111.17 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 806' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.66 159.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 20.0 110.87 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 807' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -130.73 110.01 11.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 20.0 110.899 -179.949 -117.673 -46.451 -135.565 103.796 2.029 103.79 -50.676 -132.955 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 808' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.11 -48.59 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 20.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 809' ' ' THR . . . . . . . . . . . . . 2.4 m -143.0 164.32 30.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 20.0 110.86 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 810' ' ' SER . . . . . . . . . . . . . 25.6 p -85.63 -38.75 18.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 20.0 110.909 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 811' ' ' LYS . . . . . 0.428 ' HA ' ' CZ3' ' E' ' 814' ' ' TRP . 17.5 mttp -56.51 -34.52 67.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 20.0 110.955 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 812' ' ' GLU . . . . . 0.452 ' O ' HG23 ' E' ' 816' ' ' VAL . 0.5 OUTLIER -86.04 -32.41 21.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 20.0 110.952 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 813' ' ' CYS . . . . . . . . . . . . . 1.1 m -52.5 -31.69 36.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 20.0 110.876 -179.994 -99.572 -97.088 152.062 103.789 2.03 103.786 137.128 -177.327 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 814' ' ' TRP . . . . . 0.428 ' CZ3' ' HA ' ' E' ' 811' ' ' LYS . 1.8 m0 -73.5 -53.0 11.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 20.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 815' ' ' SER . . . . . . . . . . . . . 4.4 m -50.41 -33.7 21.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 20.0 110.917 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 816' ' ' VAL . . . . . 0.594 HG11 HG13 ' E' ' 805' ' ' VAL . 57.9 t -71.49 -42.05 72.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 20.0 111.087 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 817' ' ' CYS . . . . . . . . . . . . . 86.5 m -61.73 -48.21 81.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 20.0 110.884 179.996 -67.803 -55.612 -102.458 103.851 2.029 103.831 -60.518 -78.195 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 818' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -62.13 -36.65 82.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 20.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 819' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -45.42 56.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 20.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 820' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.85 -66.8 0.39 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 20.0 110.942 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 821' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.09 -76.9 0.57 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 20.0 110.918 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 822' ' ' ASN . . . . . . . . . . . . . 2.8 p30 171.45 48.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 20.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 823' ' ' THR . . . . . . . . . . . . . 51.2 p -136.25 173.3 11.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 20.0 110.909 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 824' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.55 -178.2 6.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 20.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 825' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? 57.97 104.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 20.0 110.907 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 826' ' ' GLY . . . . . . . . . . . . . . . -164.52 128.42 1.8 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.742 -0.742 . . . . 20.0 112.512 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 827' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.73 166.61 6.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.848 0.356 . . . . 20.0 110.857 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 828' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.43 129.6 55.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 20.0 110.876 -179.999 -132.955 -50.676 -135.565 103.79 2.029 103.796 -46.451 -117.673 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 829' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.8 147.74 29.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 20.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 830' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -48.68 -31.63 7.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 20.0 110.917 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 831' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.32 -69.35 0.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 20.0 110.9 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 832' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.94 146.47 25.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 20.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 833' ' ' CYS . . . . . . . . . . . . . 47.5 t -59.8 130.21 45.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 20.0 110.869 -179.981 -177.327 137.128 152.062 103.786 2.03 103.789 -97.088 -99.572 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 834' ' ' ARG . . . . . 0.417 ' HD3' ' CE1' ' E' ' 802' ' ' PHE . 91.1 mtt180 -99.12 136.56 38.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 20.0 110.941 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 835' ' ' CYS . . . . . . . . . . . . . 33.9 m -92.1 144.52 25.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 20.0 110.816 -179.971 -78.195 -60.518 -102.458 103.831 2.029 103.851 -55.612 -67.803 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 836' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.01 178.23 7.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 20.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 837' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.201 -0.904 . . . . 20.0 110.862 -179.991 . . . . . . . . 0 0 . 1 stop_ save_